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Abstract
It is estimated that as many as 50% of people suffering from Whiplash -Associated Disorders
(WAD) may experience chronic alterations of their activities of daily living as much as 1year post injury. Despite their burden, there is little to evidence to suggest why some people
may be more likely to acquire WAD or develop chronic symptomology. Additionally, the
link between biomechanical forces at the time of impact and symptom development or
recovery is poor. As a result, interest in alternative theories such as stress system reactivity
have received interest in recent literature, but empirical methods to test them has been
lacking. Thus, the purpose of this thesis was to explore the relationship between stress and
trauma using a known stressor and a newly developed virtual reality (VR)-based car crash
simulator to better understand the immediate reaction to being involved in a motor vehicle
crash (MVC). In Chapter 2, we evaluated conditioned pain modulation (CPM) in reaction to
the cold pressor task and measured associations with indices of sympathetic and
hypothalamic-pituitary-adrenal function. It was found that only 30% of participants
experienced inhibitory CPM. Within this group, there was a positive moderate correlation
between CPM and the absolute change in skin conductance pre-to-post cold pressor task. In
Chapter 3, we explored the initial tolerability to a novel VR-based car crash simulator in
healthy subjects and also evaluated sense of presence and simulator sickness. The system was
well tolerated by a majority of participants, and it appeared that the sense of presence and
simulator sickness shared an inverse relationship. In Chapter 4, we evaluated the pain and
stress response to our VR-based car crash simulator in the form of pain pressure detection
thresholds, CPM, heart rate variability, and salivary cortisol. Over 40% of participants were
more sensitive to pain following the simulation, and this may have been associated with an
increase in parasympathetic nervous system activity and salivary cortisol. These results may
help to explain some of the heterogeneity of WAD presentations after a MVC and signify
that the pain/stress response to simulated trauma is variable.

Keywords
Conditioned pain modulation, whiplash-associated disorders, virtual reality, stress reactivity,
pressure pain detection threshold, galvanic skin response, heart rate variability, pain
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Summary for Lay Audience
While there has been much research over the last 20 years to understand car crashes, it
remains unclear why some people develop neck pain and others do not. This collection of
symptoms immediately after a car crash is referred to as Whiplash. Recent research has
suggested that neck pain after a car crash could be due to high amounts of stress that are felt
during a car crash. Unfortunately, until now there has been no way to test this theory. We
recently created a new virtual reality based simulator that is designed to mimic the
experience of being in a car crash without the physical injury. Thus, this research project was
designed to examine how healthy people react to being involved in a virtual reality car crash.
The first project in this thesis was designed to look at how healthy people react to being
stressed using a common way of generating stress. We did this by placing healthy people’s
hands into cold water and measuring their nervous system activity and their pain before and
after. It appeared that some people become less sensitive to pain and that this was associated
with the ‘fight’ aspect of the fight or flight response. For the second project in this thesis, we
wanted to see if healthy people could tolerate exposure to a virtual reality car crash. We also
measured how much they felt like they ‘were actually there’ and if they became sick or not.
Most people were able to tolerate this virtual reality car crash and that as the feeling of ‘being
there’ increased, sickness decreased. The third project in this thesis looked how healthy
people responded to a virtual reality car crash in terms of their pain and nervous system
activity. We surprisingly found that some people become more sensitive to pain after a
virtual car crash and that this was associated with the ‘flight’ aspect of the fight or flight
response. With this information, we may be able to start better understanding why some
people get neck pain after a car crash and some people do not.
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Chapter 1

1

Introduction

1.1 The Burden of Neck Pain
The experience of pain is one of the most complex, universal, and fundamental human
experiences, which is also the most common reason why patients seek medical care.1 It is
generally accepted that the individual experience of pain is the result of some
combination of biological, psychological and sociocultural factors.2 Due to its multiple
inputs, The International Association for the Study of Pain re-defined pain as, “An
unpleasant sensory and emotional experience associated with, or resembling that
associated with, actual or potential tissue damage.”3 Chronic pain is estimated to affect
18.9% of adults in Canada, with half having lived with chronic pain for over 10 years.4
Specifically, neck pain (NP) (as of 2019) constituted the 12th leading cause of years lived
with disability globally, while road injuries were the 7th leading cause of disabilityadjusted life years.5
Recent concept mapping has suggested that the impact of NP extends far beyond the
physical, with influences on performing activities of daily living, social participation and
financial consequences.6 People suffering from NP have also expressed that they have
faced misunderstanding regarding their condition from their families and employers.6
Unfortunately, despite its burden, the cause of NP is not always evident and thus makes
treatment options for its sufferers challenging.7,8 NP can arise from any structure in the
neck including but not limited to muscles, ligaments, joints, and intervertebral discs.9 As
a result, most NP has been labelled as non-specific NP to reflect this problem and can
generally be broadly sub-divided into two categories: traumatic and non-traumatic.10 One
of the most common causes of NP in a traumatic setting is exposure to a motor vehicle
crash (MVC).11
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1.2 Motor Vehicle Crashes and Whiplash-Associated
Disorders
Exposure to either a rear-end or side-impact MVC can impart an accelerationdeceleration transfer of energy to the head and neck, which is known as a Whiplash
mechanism of injury.12 The term MVC is used instead of motor vehicle accident (MVA)
to reflect that calling these events accidents undermines the experience of their
sufferers.13 In turn, Whiplash-Associated Disorders (WAD) refer to the range of
symptoms that result after a MVC from an acceleration-deceleration mechanism of
injury.14 The symptoms of WAD can include but are not limited to: neck pain, loss of
range of motion of the neck, neurological signs and even fracture of the cervical spine.15
Due to the myriad of presentations, the Quebec Task Force classified patients with
whiplash16 as:
-

Grade 0: No injury. No neck complaints. No physical signs

-

Grade 1: Injuries for which there is a complaint of neck pain, or stiffness, or
tenderness. No physical signs

-

Grade 2: Injuries for which there is a neck complaint and physical sign such as
loss of range of motion or point tenderness

-

Grade 3: Injuries for which there is a neck complaint and neurological signs such
as decreased sensation and/or weakness

-

Grade 4: Injuries for which there is a neck complaint and cervical fracture

Interest in prognosis from whiplash injuries has seen great interest as half of affected
adults have resolution of their symptoms (without intervention) while the remainder will
experience either prolonged recovery or chronic symptomology.11,17 Prior work has also
shown that, amongst other factors, the experience of higher pain severity shortly after
injury is a strong predictor of poor outcomes 6 to 12 months later.18 Despite numerous
studies elucidating various prognostic factors in the recovery of WAD, recovery rates
have changed little in the last 30 years, and the mechanisms behind WAD remain
elusive.19,20
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1.3 Historical Models of WAD
Historical models of WAD have been explored from the basis of a pathoanatomical
model of injury.19 Cadaveric biomechanical studies demonstrated that in a rear-end
MVC, the cervical spine experiences a reversed S- shaped curve leading to lower cervical
spine hyperextension and upper cervical spine flexion.21,22 Thus, it was postulated that
this mechanism could result in increased shearing and tensile forces at individual cervical
levels leading to injury of the soft tissues of the neck.21,22 Most notably, the facet joints
of the cervical spine have been implicated in NP due to their potential for nociception and
their capsular strain during a whiplash event.22–24 Cervical radiofrequency neurotomy of
facet joints in patients with chronic WAD has been shown to improve pain and disability
scores even 3 months following the procedure.24 However, even in patients who received
radiofrequency neurotomy of their facet joints, they still present with mild to moderate
pain.24
In spite of biomechanical studies, traditional diagnostic imaging (e.g., plain films or
magnetic resonance imaging) have been unable to consistently and accurately detect the
presence of soft tissue lesions in patients with WAD.25 Nevertheless, it has been
suggested that 40 to 45% of patients with chronic WAD likely have a peripheral articular
lesion responsible for their NP.19 There also appears to be little association between crash
parameters such as speed and direction of collision, or awareness of impending collision
and recovery from development of WAD.17,19,26 Further complicating WAD, is that there
is little evidence to suggest why one individual may experience a lack of symptoms from
a high force collision, while someone else may present with significant symptomology
from a low-speed perturbation.20 Due to the disparity between these findings, newer
models for understanding WAD have been proposed.

1.4 New lntegrated Models of WAD
To try and reconcile gaps in the literature and to help explain the heterogeneity of the
clinical presentation of WAD, Walton and Elliot (2017) proposed an Integrated Model of
WAD, drawing upon previous work in both the Fear-Avoidance Model of Pain as well as
the Diathesis-Stress model of pain.19 The Fear-Avoidance model of pain postulates that
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when pain is experienced, there are two likely outcomes.27 The first is one of recovery
where the situation is seen as non-threatening, thereby the person is likely to stay
engaged in functional activities that promote recovery. The second outcome is one of
prolonged suffering, in which fear of pain leads to fear of movement which leads to a
vicious cycle where pain can be catastrophized leading to the potential for further pain
and suffering. The Diathesis-Stress model of pain on the other hand sought to give
considerations to the interactions of individual predisposing factors in the reaction to
trauma.2
Diatheses can be individual personal and contextual variables (e.g., psychological,
genetic) that either lead to protection or vulnerability in the context of injury.19 Walton
and Elliot (2017) built upon these theories to present an integrated model of WAD that
fully considers the interaction effects between psychological and neurobiological systems
as well as their contributions from personal and environmental factors.19 Also included in
this model was the idea that the MVC acted as a unique catalyst that led to a cascade of
both physiological and psychological responses to protect from injury.19 These responses
are thought to include an acute stress response to trauma, that has been postulated to be
abnormal or maladaptive in those who develop chronic WAD.19,28

1.5 Stress Reactivity and Pain
A stressor can be defined as circumstances that threaten the physical and/or psychological
state of the individual.29,30 In response, the individual may experience distress which
consists of a psychological appraisal of the situation and can include both the feelings of
anxiety and/or feeling overwhelmed.30 While the term distress expresses a negative
connation, some degree of distress is considered advantageous in reaction to a stressor, as
individuals who experience little distress may also be at risk of developing
psychopathology.19,31Distress is a separate experience from that of eustress which has
been typically been defined as ‘good stress’ and includes an optimal stress response to a
stressor to a stressor that the individual has appraised as non-threatening (e.g., exercise).32
The psychological appraisal of the situation at hand is assessed by the prefrontal cortex,
hypothalamus, and amygdala which determine if the circumstance is threatening to the
homeostasis of the body.33
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Next, the body experiences two major physiological processes: the fast activation of the
sympathetic nervous system (SNS) component of the autonomic nervous system (also
known as the sympathetic-adreno-medullary (SAM) axis), and the slow activation of the
hypothalamus-pituitary-adrenal (HPA) axis.33–35 Activation of the SNS leads to an
increase in heart rate, blood pressure, and perspiration, while activation of the HPA axis
ultimately leads to the release of the stress hormone cortisol.33,34 Cortisol aids the body in
its ability to use glucose for fuel and is also a potent anti-inflammatory.36 However, under
chronic stress conditions, elevated cortisol levels can lead to its dysfunction causing
increased systemic inflammation and pain.36 Acute activation of these systems (SNS &
HPA axis) can lead to stress-induced analgesia (SIA) to help protect the individual from
harm, which is controlled by descending opioid and non-opioid brain circuits.37,38
If the stressor includes a noxious or painful stimulus, then activation of a similar yet
unique system known as Diffuse Noxious Inhibitory Control (DNIC) can also occur
simultaneously.38 DNIC consists of a spinal-medullary-spinal pathway that can be
activated for pain inhibition in response to a painful stimulus, more commonly referred to
as ‘pain inhibits pain’.39 Interest in DNIC and stress reactivity in chronic WAD patients
has been gaining interest in recent years, as both impaired DNIC40 and stress
reactivity28,41 have been implicated in patients suffering from chronic WAD. Due to these
findings, there has been a push to try and identify both physical and psychological factors
that may be predictive in determining outcomes after whiplash injuries for the
development of chronic pain.42

1.6 Pain and Stress Measurement as Biomarkers for
Chronic Pain
Conditioned Pain Modulation (CPM) is one technique that has seen increasing use and is
conceptualized as a means to evaluate the functioning of pain inhibitory pathways (i.e.,
DNIC).43 CPM protocols typically consist of exposing participants to a testing stimulus
before and after exposing them to a different noxious conditioning stimulus. The testing
stimulus is commonly a measure of pain pressure detection threshold (PPDT)(e.g.,
mechanical or thermal) and the difference in threshold between the pre- and postexposure to the conditioning stimulus is considered the CPM.43,44 Assuming well-
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functioning DNIC, pain thresholds normally increase (the system becomes less sensitive
to the testing stimulus) following exposure to the conditioning stimulus, though negative
CPM, considered dysfunctional DNIC, is a consistent feature of chronic pain
presentations (e.g., fibromyalgia).45 However, recent evidence has suggested that CPM
may not be a universal finding, even among healthy individuals.44,46
Stress reactivity is also of interest in the context of WAD, as chronic WAD shares
common psychological sequelae with those suffering from post-traumatic stress disorder
(PTSD).19,47 Stress reactivity can be captured using non-invasive measurement tools such
as Galvanic Skin Response and Heart Rate Variability (HRV).48,49 Galvanic Skin
Response (GSR) has been shown to be one of the quickest non-invasive evaluative tools
through which to evaluate a physiological stress.50,51 GSR is a measure of a change in the
electrical properties of the skin, where more sweat (moisture) reduces current resistance
in reaction to a noxious stimulus due to activation of the SNS.52 This happens on a
millisecond scale and is completely outside of voluntary control, making it an attractive
metric for stress research.50,53 HRV is a physiological measure that has been used as a
clinical proxy of autonomic tone (sympathetic: parasympathetic balance) in healthy and
diseased states.54,55 While there are many methods to measure HRV using standard ECG
recordings, the time domain methods (e.g., root mean square of the successive differences
(RMSSD) between normal heartbeats), are some of the simplest to perform, appear to be
clinometrically robust, and can be captured in a 5 minute period.55 HRV in particular has
been shown to be decreased in subjects with chronic WAD in comparison to healthy
controls.56

1.7 Opportunities for Innovative Technologies in
Understanding WAD
Unfortunately, many of these newly proposed theories and/or models of WAD have
remained firmly fixed in the theoretical phase as it isn’t feasible or ethical to place
subjects in live car crashes for scientific research.57 Emerging technologies in the form of
driving simulators could be a novel method through which the experience of a MVC can
be replicated without the potential for tissue damage or excessive biomechanical forces.57
To date, lab-based research involving driving simulators has been limited to exposure
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therapy studies for treatments of patients suffering from PTSD or intervention to alter
driving behaviour.58,59 One promising technology in this domain is the use of virtual
reality (VR). VR can be understood as technologies that produce a virtual environment
via hardware or software that simulates real-world objects or events and allows the
subject to interact with the virtual environment.60,61 VR relies on interactivity and
immersion to create a sense of presence, and interactivity to either replicate real world
environments or imaginative settings.62 Immersion in this context refers to the objective
level of sensory feedback and/or fidelity that a of which a VR system is capable.63
In an interesting study simulating a MVC before the advent of VR, Castro and colleagues
(2001) exposed healthy participants to what they termed a placebo car crash. This
experimental setup was designed such that participants would experience sudden braking,
and glass shattering to believe that they had been involved in a rear-end MVC without
actual vehicle collision.64 This study reported that up to 20% of participants can
experience symptoms of WAD, even in reaction to a placebo car crash.64 It could be
argued however that this experimental setup was not as immersive as that of a VR-format
in which the subject can be fully immersed in the experience. As such, exposure to a VRbased MVC may be able to allow subjects believe that they are participating in a MVC,
such that the effects of low-speed MVC with low biomechanical forces can be directly
observed. Additionally, the work of Castro and colleagues (2001) also relied on symptom
self-report, and therefore it is unclear if there were any objective physiological findings
present in those that experienced WAD-like symptoms.64 Again, a VR-based MVC could
be advantageous in simulating various MVC crash types (e.g., rear-end vs side-impact)
with real-time physiological monitoring from both pain and stress measurement
perspectives.

1.8 Overall Purpose
The overall purpose of this thesis was to explore CPM and measures of stress system
reactivity in reaction to both a known stressor (e.g., cold pressor task) and a novel VRbased road collision simulator. We understood that this line of work would likely raise
more questions than it would answer but were hopeful that it might help to illuminate
why symptoms of WAD may persist in the absence of biomechanical forces that impart
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tissue damage. It was also our hope that this work would fundamentally aid patients in
understanding why they have their symptoms while others do not. Thus, the work of this
thesis is presented in three separate but related main chapters.
The aim of Chapter 2 of this thesis was to identify meaningful CPM in a cohort of
healthy young adults in reaction to the cold pressor task and to explore relationships with
measurements of stress system reactivity (e.g., skin conductance and salivary cortisol).
We envisioned this study as a comparator with other studies examining pain responses to
different conditioning stimuli. This study was also designed to contribute to the growing
body of literature in identifying meaningful CPM.
The aim of Chapter 3 was to explore the initial tolerability of participants using a novel
virtual reality-based road collision simulator designed to mimic the experience of being
the passenger in a car crash. This study was also designed to gather user feedback
regarding sense of presence and simulator sickness to help refine the simulator for future
use. Adverse events were also recorded to help refine the simulator for future study.
The aim of Chapter 4 of this thesis was to begin to examine the range of physiological
reactions to a novel virtual reality-based road collision simulator. We explored CPM
using the VR-based MVC as a conditioning stimulus with PPDT as our testing stimulus,
again examining for meaningful CPM based on literature recommendations. We also
explored any relationships with measurements of autonomic nervous system reactivity
such as heart rate variability.
We envisioned this work as the start of a new research initiative designed to explore the
experience of involvement in a MVC without the potential for tissue injury. By viewing a
car crash as a catalyst towards the development of neck pain, we are hopeful that future
work can continue to shed light on the heterogeneity of the condition that is WAD.
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Chapter 2

2

Exploring the Relationship between Conditioned Pain
Modulation Efficacy and Stress System Reactivity in
Healthy Adults in Reaction to the Cold Pressor Task

2.1 Introduction
Conditioned Pain Modulation (CPM) is a technique used to evaluate the functioning of
pain inhibitory pathways in the human body.1 CPM protocols consist of exposing
participants to a testing stimulus before and after exposure to a noxious conditioning
stimulus, which historically has been the Cold Pressor Task (CPT), though a variety of
conditioning stimuli can be used. 1–3 Previous literature has demonstrated that the use of
cold water immersion can be used for sessions up to three minutes in duration before selfreported pain becomes too intense.4 The testing stimulus is commonly pain detection
threshold and the difference in the testing stimulus threshold between the pre- and postexposure is considered the metric for CPM.1 Prior recommendations have suggested that
CPM is best conceptualized as the absolute change or percentage change in the testing
stimulus from pre-to-post exposure in order to compare results across studies and
institutions.4 In healthy adults, it is thought that CPM is typically positive (i.e., an
increase in pain threshold) in nature, though prior work has found that negative/impaired
CPM is a common feature of chronic pain syndromes.5
Complicating this matter is that some prior studies have identified non-responders in
CPM research, with a paucity of evidence exploring the proportion of healthy participants
without pain that also show reversed CPM under normal clinical conditions.4 As such,
there have been attempts to define what constitutes true meaningful change in CPM
measurements, beyond simple measurement error. Previously, Kennedy and colleagues
(2020) used a distribution-based statistical approach based on two standard errors of
measurement (SEM) of the testing stimulus to classify participants as having experienced
inhibition (i.e., increase in pain threshold), facilitation (i.e., decrease in pain threshold),
and non-response (i.e., no appreciable change).6 Despite this classification system, it is
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unclear what individual factors may contribute to the experience of these responses,
though higher state anxiety was associated with inhibitory CPM effect.6
Geva and Defrin (2018) also recently found a relationship between CPM and perceived
stress in that those participants who experienced a perceived high stress response had
reduced CPM.7 However, these authors were unable to demonstrate a relationship
between CPM and physiological measures of the stress response such as salivary cortisol
or Galvanic Skin Response (GSR), nor did they explore meaningful CPM as it relates to
these measurements. Salivary cortisol and GSR are promising measures of stress system
reactivity as they provide estimates of sympathetic nervous system (SNS) and the
hypothalamic-pituitary-adrenal (HPA) axis.8
In recent years, CPM has been highlighted as a potential biomarker for the development
of chronic pain, although questions remain regarding its validity as a biomarker
considering it is fully dependent on participant perception of and willingness to report
pain.4,9 Concurrently, a maladaptive or exaggerated stress response has been reported as a
potentially important mechanism through which chronic pain following trauma is
developed.10,11 Inversely, it has also been suggested that people who experience a lack of
a stress response or a blunted one, may also be at risk of developing pain and/or
psychopathology following trauma.12,13 As such, it appears that there may be a
relationship between stress (exaggerated or blunted) and pain; however, the directionality
of this relationship requires further investigation.14 Thus, the purpose of this study was to
explore the relationship between statistically meaningful CPM after exposure to a CPT
and its associations with measures of stress system reactivity (i.e., salivary cortisol and
GSR).

2.2 Methods
Study Design
This was a cross-sectional study with repeated measures design. Participants had their
pain pressure detection threshold (PPDT), GSR, and cortisol measured before and after
exposure to a CPT.
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Participants
A convenience sample of participants was recruited from Western University between
February 2019 and March 2020. Eligible participants were 18 years or older, without
recent musculoskeletal injury for two weeks, and could read/write conversational
English. Exclusion criteria were: infection, cardiovascular instability, cancer, Raynaud’s
phenomenon, cryoglobulinemia, stroke, multiple sclerosis, amyotrophic lateral sclerosis,
and cervical radiculopathy. Participants were required to discriminate between thermal
stimuli using hot/cold test tubes and light touch using a 200mg Von Frey filament on the
neck as part of the screening protocol for eligibility. Recruitment was purposive to ensure
equal representation of sexes given the clear sex bias in biomedical research.15 This study
was approved by the Health Sciences Research Ethics Review Board at Western
University (London, ON, Canada) prior to commencement and all participants provided
written informed consent and the rights of the subjects were protected.
Experimental Protocol
All participants were asked to refrain from consumption of food/ drink, analgesic
medications, and any physical activity for the hour before testing. On the first testing day,
participants completed a study-specific demographic questionnaire indicating their age
and sex. Participants then sat in an isolated room for five minutes with consistent
lighting, noise, and temperature.
PPDT
PPDT was evaluated using the protocol of Walton et al. (2011).16 This protocol consists
of testing PPDT at upper fibers of the trapezius muscle using a handheld digital
algometer (Wagner FDX-25, Wagner Instruments, Greenwich CT, USA) on the
participant’s dominant side. Increasing force was applied to the angle of the upper
trapezius and participants were instructed to verbalize ‘there’ when the sensation changed
from pressure to pain. The rate of application was 5N/second and the rater was trained
until they could perform this rate of application consistently. The value of the algometer
at verbalization was recorded in kilograms of force (kgf). The process was repeated three
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times with 30 seconds between testing, and the average of these three sessions was the
baseline PPDT.
GSR
In order to evaluate peripheral sympathetic nervous system activity, participants had their
GSR measured using ADInstruments PowerLab (PowerLab®, ADInstruments, Sydney,
Australia) at a sampling rate of 1000 Hz using two finger cuffs on the participants nondominant hand on the second and fourth fingers. GSR was measured in microsiemens
(uS) zeroed to each participant prior to use to determine a relative change in skin
conductance from their baseline resting state. Measurements relative to each subject’s
resting state were used to avoid any baseline variability in GSR which may have been
influenced by circadian systems, to isolate the stress response to the stressor used in the
present study.17,18 GSR was recorded over a five-minute baseline period, during the
experimental pain protocol, and two 5-minute periods during recovery (0 to 5 minutes, 5
to 10 minutes). Participants were also asked to minimize any movements of their nondominant hand and fingers to minimize measurement errors.
Salivary Cortisol
With the GSR sensors still in place, a salivary sample was collected from each participant
prior to the CPT using a small poly-cotton swab. Each participant rolled the swab around
the inside of their mouth for about 30 seconds before returning it to a sterile salivette. The
salivette was then sealed, and immediately transferred to a -30C freezer for later off site
analysis. Salivary cortisol (Cortisol (Saliva) ELISA, Alpco (Salem, NH, USA), cat no.11CORHU-E01-SLV) was analyzed using typical industry standard approaches based on
the specifications set by the manufacturer and all samples were run in duplicate, whereby
the values were the average of the two duplicate samples.

Cold Pressor Task
Experimental pain was simulated with the CPT. Similar to the protocol of Kaunisto et al.
(2013),19 participants submerged their dominant hand up to the wrist into an ice-water
bath (2-4 degrees centigrade) in a cooler with dimensions 16.5 cm x 12.4 cm x 13 cm.
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The ice was separated from the participants hand with a mesh basket and temperature was
monitored using a submersible digital thermometer. The water was mechanically agitated
regularly and temperature was checked in several spots to ensure a consistent
temperature. No pump was used as preliminary testing found interference with the GSR
readings. Participants kept their hand submerged until they experienced an 8/10 on the
Numeric Pain Rating Scale (NPRS) (0 = no pain to 10 = extreme pain) or until 90
seconds had elapsed, whichever came first. Kennedy et al. (2016) recently highlighted
that a conditioning stimulus must not be overly painful, otherwise it may not be tolerated
by all participants.4 As such, an 8/10 on the NPRS was selected as a cut-off as it was
deemed sufficiently noxious, but not overly painful such that the CPT could be tolerated
by a majority of participants. Participants rated their pain every 10 seconds. Cold
endurance time was recorded to the nearest 0.1 seconds using a digital stopwatch.
Following the CPT, participants dried their hands and sat quietly for 30 seconds after
which PPDT and salivary cortisol were re-evaluated. PPDT was re-measured by the same
rater that performed the baseline test in a sequential manner. GSR measurement
continued throughout both the CPT and during recovery for offline analysis.

Statistical Analysis
Descriptive statistics (mean, standard deviation) were calculated for participant
demographics, PPDT, CPM, GSR, and salivary cortisol at baseline and after the CPT. For
descriptive purposes, participants’ cold endurance time was coded as either 1 (immersion
= 90 seconds) or 2 (immersion < 90 seconds) and was reported as the frequency of
participants to reach the full immersion time. The other metrics (PPDT, GSR, and
salivary cortisol) were retained as ratio-level variables (microsiemens or ng/ml). Data
were visualized via box-and-whisker plots and outliers were identified through visual and
statistical tests of normality (Kolmogorov-Smirnov tests). PPDT values were
logarithmically transformed for parametric statistics, as they were not normally
distributed. Data are reported in their un-transformed state for comparison to the
literature.
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A one way repeated measures analysis of variance (rmANOVA)was used to detect any
significant changes in mean 5-minute GSR intervals at each testing point compared to
baseline testing, with a Bonferroni correction factor applied (T1 = 5 minute baseline, T2
= during CPT, T3 = 0 to 5 minutes after CPT, and T4 = 5 to 10 minutes after CPT).
While GSR can be measured with parameters like amplitude or recovery time,20 only
average skin conductance was used due to the prolonged exposure of the CPT, which was
not an acute startle event. A paired samples t-test was used to compare mean difference in
cortisol and PPDT before and after the CPT. The difference between PPDT before and
after the CPT was the CPM and was analyzed as both absolute change (CPMABS = Post Pre immersion (in kgf)) and percent change (CPMPERCENT = ∆CPMABS/Pre immersion kgf
x100) as per the recommendations of Kennedy et al. (2016).4
Meaningful CPM
Next, the recommendations of Kennedy et al. (2020) were used to explore meaningful
CPM.6 The reliability of the baseline PPDT was evaluated using an intraclass correlation
coefficient (ICC3,1). ICCs were interpreted as suggested by Shrout & Fleiss21 where
values less 0.4 were poor, between 0.4 and 0.59 was fair, between 0.60 and 0.75 was
good, and greater than 0.75 was excellent. From this, the standard error measurement was
calculated for the baseline PPDT ((SEM = pooled standard deviation of baseline PPDT
(SDpooled)√(1-ICC)). Per the protocol of Kennedy et al. (2020) + 2 SEM were used to
group participants into three classification groups (inhibition = increase in
threshold/decreased sensitivity, facilitation = decrease in threshold/increased sensitivity,
and non-response).6 Both the absolute and percentage change of + 2 SEM were used to
account for those participants who may have had a minor increase in absolute PPDT, but
a large percentage change relative to their baseline measurement. Descriptive values of
both the pain and stress metrics were also calculated for participants within these groups.
Associations between CPM Classification and Indicators of Stress
Pearson correlations were used to explore any initial relationships between CPM
classification and the changes in salivary cortisol and GSR before and after the CPT as a
measure of stress system reactivity. Strength of Pearson correlations were interpreted
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using the recommendations of Mukaka (2012), whereby: <0.30 (negligible), 0.30 to 0.50
(low), 0.50 to 0.70 (moderate), 0.70 to 0.90 (high), >0.90 (very high).22 Scatter plots were
used to visually model the date for interpretation.
All statistical analyses were completed using IBM SPSS Statistics Version 27 and the pvalue for statistical significance was set at 0.05.

Sample Size Calculation
For this study, no formal sample size was calculated due to the exploratory nature of the
work, though a similar number of participants (n=50) were sought compared to other
studies investigating meaningful CPM in healthy adults.6

2.3 Results
Descriptive Statistics
50 healthy participants (male = 25, female =25) were included in the study with a mean
age of 24.5 + 3.3 years (18 to 35)(Table 1). No subjects reported their sex as different
from their self-reported gender; thus, only sex is reported. 52% (26/50) of participants
tolerated the full 90 seconds of the CPT used in the present study. Mean PPDT values
across the full sample were not significantly different from baseline to after the CPT; see
Table 2 for a full description of values. The one-way repeated measures ANOVA
revealed that there was a statistically significant main effect for testing time for mean 5minute GSR (F=44.58, p=0.001), with post hoc pairwise comparisons indicating GSR
was significantly elevated from baseline (6.08 + 8.77 uS, 95%CI: 3.45 to 8.72 uS) at all
subsequent time points (all p<0.001) during the CPT (15.25 + 9.30 uS , 95%CI: 12.45 to
18.04 uS), for 0 to 5 minutes after (13.84 + 8.51 uS , 95%CI: 11.28 to 16.40 uS), as well
as 5 to 10 minutes after (14.07 + 9.23 uS , 95%CI: 11.30 to 16.84 uS). See Figure 1 for a
visual description of GSR values across testing points. When analyzed across the entire
sample, CPMABS was 0.24 + 1.04 kgf (95% CI: -0.06 to 0.53kgf) while CPMPERCENT was
7.73 + 21.00% (95% CI: 1.76 to 13.70%). Cortisol values were not statistically
significantly different before and after the CPT (Table 2).
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Meaningful CPM
The reliability for baseline PPDT was (ICC3,1), which was 0.97, indicating an excellent
level of reliability based on the recommendations from Shrout & Fleiss.21 Thus, for this
study the SEM of PPDT was 0.39 kgf. Accordingly, participants who had greater than a
+0.78 kgf (or +18.3% of baseline mean PPDT)) increase in PPDT were termed
modulation, a decrease greater than -0.78 kgf (or -18.3% of baseline mean PPDT) were
termed facilitation, and participants who experienced anything between were described as
having experienced non-response. 15 participants (30%) experienced inhibition of their
pain thresholds, 6 participants (12%) experienced facilitation, while the remainder had no
significant change of their PPDT values (58%). See Table 3 for a full description of
PPDT and CPM values within these sub-groups (inhibition, facilitation, and nonresponse).
Associations with Indicators of Stress
When disaggregated by class, there was a moderate positive correlation ranging from r =
0.63 to 0.69 (p<0.011) between CPM (CPMABS or CPMPERCENT) and the absolute change
in GSR from baseline to immersion, or from baseline to the immediate 5 minutes after
immersion, but only in the 15 participants who experienced inhibition of their PPDT
values. See Table 4 for a full description of the correlational matrix between CPM and
stress measures in the inhibition group. Within the non-response group, there was a low
negative correlation of r = -0.47 (p=0.01) between CPMABS and the absolute change in
GSR from baseline to the immediate 5 minutes after immersion. There were no other
statistically significant relationships within the non-response group. There was no
significant relationship between CPM and any indices of SNS activity in the group that
experienced facilitation. There were also no significant relationships between CPM and
the change in salivary cortisol in any of the classes.

2.4 Discussion
The purpose of this study was to explore the associations between indicators of stress
system reactivity (i.e., salivary cortisol, GSR) and meaningful CPM within healthy young
adults in reaction to a standard experimental pain protocol using noxious cold (CPT). It
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appeared that in reaction to the CPT, when analyzed as a group, there was no significant
CPM effect, as PPDT values remained statistically unchanged. Salivary cortisol values
also remained unchanged in reaction to the CPT. This was despite a statistically
significant increase in GSR values at all timepoints compared to baseline, suggestive of
an increase in sympathetic nervous system activity. When we evaluated for meaningful
CPM in relation to + 2 SEM, a majority of participants experienced no appreciable
change of their PPDT (58%), while 30% of participants experienced the expected
inhibition (i.e., increase in PPDT) of their pain sensitivity. Within this group of
participants who experienced inhibition, there was a moderate positive association with
the change in GSR, suggesting that pain modulation may be related to the magnitude of
the stress response in reaction to the CPT in those who can suppress their pain
experience.
Approximately half of the current study’s participants were able to complete the full 90
seconds of submersion for the CPT. Previous work by Kaunisto et al. (2013) found that
24% of their sample could tolerate cold water immersion for the full 90 seconds, however
this result may have been explained by the presence of chronic pain.19 One criticism of
using cold endurance in this manner is the presence of a ceiling effect. However, as there
were a large amount of participants in the present study and previous investigations19 that
could not tolerate the full immersion time, 90 seconds of immersion may still be
appropriate. Future work is required to establish an upper limit on CPT immersion time.

There is a growing body of evidence that PPDT inhibition in CPM protocols is not a
universally experienced phenomenon even in healthy participants, and our results are in
agreement with the literature. Locke et al. (2014) first evaluated CPM with respect to 1
SEM of their testing stimulus (PPDT), finding that 92% of participants experienced an
inhibitory CPM effect in reaction to the CPT as a conditioning stimulus.23 However, this
analysis was only conducted on a pilot of 10 participants. In contrast, Vaegter et al.
(2018) found that only 62% of participants (total sample = 26 participants) experienced
pain inhibition using cold water immersion as a conditioning stimulus and mechanical
PPDT as the test stimulus, using 1 SEM of the test stimulus to classify participants as
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responders.24 To help increase the confidence in true change, Kennedy and colleagues
examined meaningful CPM in relation to + 2 SEM of PPDT (to reflect a 95% confidence
interval), finding that 59% of participants (total sample = 50 participants) experienced
inhibitory CPM in reaction to a cold conditioning stimulus, while up to 6% of
participants experienced facilitation of their PPDT across testing paradigms.6

As such, it appears that CPM responses can be categorized as inhibitory (i.e., increase in
pain threshold), faciliatory (i.e., decrease in pain threshold), and non-response. Future
work will be required to ascertain the individual characteristics of participants that lead to
these responses, and to clarify which response could be predictive in the development of
conditions like chronic pain. Interestingly, it appeared that the participants who
experienced inhibitory CPM in our study, had a lower PPDT at pre-test compared with
those in the faciliatory CPM cohort who experienced a higher base PPDT. This may
reflect that those who are able to experience CPM and exhibit efficient diffuse noxious
inhibitory control have a reserve that they are able to use when exposed to a noxious
stimulus. Previous work conducted by Grouper et al. (2019) also suggests that those who
are less sensitive to pain, experience less pain inhibition following a CPM protocol.25
Larger samples will be required to investigate these CPM responses with respect to
individual variability.

Our study suggests that there exists a relationship between pain modulation and
sympathetic nervous system activity in participants who experienced inhibitory CPM, as
the change in PPDT values were moderately positively correlated with the change in
GSR values both during and after the CPT. This relationship was reversed in the
participants who had a non-response of their CPM. This is somewhat unsurprising, as
acute stress can lead to an increase in sympathetic nervous system activity,26 which may
lead to stress-induced analgesia.27,28 The CPT as a physiological stressor has also been
known to produce strong sympathetic nervous system activity.26,29 These findings are in
contrast to those of Geva and colleagues (2018), who found a reduction in CPM in
participants who perceived themselves as having a high stress response.7 However, we
did not evaluate the appraisal of each participant to determine whether or not they were
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cognitively experiencing high or low stress. As such, cognitive appraisal of the situation
could partially explain the 12% of participants in the present study who experienced
facilitatory CPM. Geva and colleagues (2014) also suggested that pain inhibition may
only result when there is a perceived risk of injury, and when risk of injury is low,
hyperalgesia could result.30 In all likelihood, the relationship between inhibitory CPM
and stress likely follows a curvilinear relationship compounded by the degree of
physiological stress and cognitive appraisal of the stressor involved. Future work is also
required to understand why a large percentage of subjects in both the present study and
previous investigations experience non-response in terms of CPM. Despite previous work
suggesting that individual factors (e.g., age, sex, attention, physical activity levels, and
genetics) play a role in CPM,31 it is unclear how they factor into identification of
meaningful CPM.

Salivary cortisol levels of the participants in the study were elevated compared to
normative values reported in the literature.32 One explanation for this may be that as the
cohort consisted of graduate level students, higher levels of stress and anxiety may have
been present leading to elevated salivary cortisol levels. We were also unable to detect a
relationship between CPM and the change in salivary cortisol as an indicator of the HPA
axis. There are various explanations for these findings. On one hand, as cortisol has been
known to peak 10 to 20 minutes after an acute stressor it may be that our study protocol
measured cortisol too early to detect true change.10,14 Additionally, we did not rigorously
control for time of day for our data collection. To circumvent this issue, we examined for
the relationship between the change in PPDT and salivary cortisol to evaluate the cortisol
reactivity of each participant. Thus, we believe the first explanation to be the more
plausible of the two. These findings taken together suggest that the SNS may be
implicated in the pain inhibition response that in those experiencing inhibitory CPM after
exposure to an acute stressor. It is also possible that since our CPT did not include a
social-evaluative element, a smaller change in cortisol reactivity was demonstrated.29

Limitations
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There are limitations that should be addressed in the present study. As subjects were
aware of the impending pain from the CPT, it is possible that the expectation of pain
impacted the salivary cortisol data collected. However, seeing as GSR values increased
significantly after the CPT, we believe that this is unlikely. As mentioned earlier, we did
not control for time of day which may have impacted the stress response of each
participant. Future work will want to control the time of day where cortisol is collected to
allow for more robust comparisons. Our also cohort consisted of university students who
may have had similar psychosocial tendencies that influence the pain
experience.33Accordingly, our results may not apply to people from different
socioeconomic statuses or with poorer health literacy. Due to interference with our GSR
measurement devices, a circulating pump was not used, and we accept that a warm
envelope could have formed around each participant’s hand during the CPT. However, as
almost half the sample could not tolerate the full 90 seconds of the CPT, we believe that
it was sufficiently painful to induce a CPM effect. As the present study is cross-sectional
in nature, we were unable to explore any causal relationships between CPM and GSR. It
should be noted that CPM protocols have been known to vary across different
investigations, using different conditioning and testing stimuli.4,34As such, it is unclear if
the results of our study would have varied had used a different CPM protocol. Sequential
evaluation of the test stimulus has been suggested to be a better representation of CPM
responses as it may be less prone to distraction than parallel designs.35 However, future
work is required to determine both the most appropriate conditioning stimuli as well as
the timing of the test stimulus is CPM studies.

2.5 Conclusion
In conclusion, only 30% of healthy adults in our study experienced inhibition of their
pain threshold in reaction to a CPT. This appeared to be associated with an increase in
sympathetic nervous system activity, as measured by GSR, but was not associated with
cortisol reactivity. Further work is required to examine for the presence of other
individual variables which may contribute to the experiences of the various CPM
responses (such as cognitive appraisal). Future research may also want to identify which
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CPM responses may be useful as a biomarker for the development of chronic pain
conditions.
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Table 1: Participant Characteristics. Data are presented as mean + standard
deviation. Range is provided in brackets where applicable.
Males

Females

Total

Sample Size (n)

25

25

50

Age (years)

24.2 + 3.9 (18-35)

24.8 + 3.9 (21-30)

24.5 + 3.2 (18-35)

Height (cm)

178.6 + 7.2 (167.6-194.0)

166.3 + 7.4 (149.9-177.8)

172.5 + 9.5 (149.9-194.0)

Weight (kg)

78.8 + 12.5

61.3 + 8.3 (47.7-81.8)

70.1 + 13.7 (47.7-104.5)

(57.0-104.5)
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Table 2. Descriptive values for group PPDT, CPM, Salivary Cortisol, and GSR
before and after CPT. Data are presented as mean + standard deviation. A 95% CI
is provided in brackets.
Baseline

After CPT

PPDT (kgf)

4.31 + 2.03 (3.70 to 4.90)

4.57 + 2.20 (3.92 to 5.23)

GSR(uS)

6.13 + 8.96 (3.50 to 8.76)

12.92 + 9.46 (10.14 to 15.70)

Salivary Cortisol (ng/ml)

27.32 + 11.32 (24.11 to 30.54)

28.17 + 12.20 (24.71 to 31.64)

Note: PPDT: Pain pressure threshold; CPM: conditioned pain modulation; kgf: kilograms of force; GSR: Galvanic Skin Response; uS:
microsiemens; ng/ml: nanogram per milliliter
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Table 3. Descriptive values for PPDT and CPM within classification groups. Data
are presented as mean + standard deviation. A 95% CI is provided in brackets.
Inhibition (n =15)

Facilitation (n=6)

Non-response (n = 29)

Baseline PPDT (kgf)

3.92 +1.85 (2.90 to 4.95)

6.29 + 2.90 (3.24 to 9.33)

4.09 +1.75 (3.42 to 4.76)

Post PPDT (kgf)

5.34 + 2.62 (3.89 to 6.80)

4.99 + 2.54 (2.32 to 7.66)

4.03 + 1.73 (3.37 to 4.69)

CPMABS (kgf)

1.42 + 0.82 (0.97 to 1.87)

-1.29 + 0.74 (-2.07 to -0.51)

-0.06 + 0.34 (-0.19 to 0.07)

CPMPERCENT (kgf)

35.27 + 6.79 (31.51 to 39.04)

-21.61 + 8.03 (-30.04 to -13.18)

-0.44 + 8.78 (-3.78 to 2.89)

Note: PPDT: Pain pressure threshold; CPM: conditioned pain modulation; kgf: kilograms of force.
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Table 4. Correlational matrix between CPM and stress response measures within
the Inhibition group.
CPMABS

CPMPERCENT

∆GSR (during CPT)

∆GSR (after CPT)

∆Salivary
Cortisol

CPMABS

-

0.43

0.65**

0.63*

0.20

CPMPERCENT

-

-

0.69**

0.65*

0.34

-

0.96**

0.44

-

0.35

∆GSR (during CPT)
∆GSR (after CPT)
∆Salivary Cortisol

-

Note: CPM: conditioned pain modulation; kgf: kilograms of force; GSR: Galvanic Skin Response; uS: microsiemens; ng/ml:
nanogram per milliliter
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Figure 1. GSR values at each testing time point with 95% confidence intervals for
entire sample of participants. * denotes significantly different from baseline values
at p< 0.001.
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Chapter 3

3

Initial Tolerability and Reactions to a Novel VirtualReality-Based Road Collision Simulator: An Exploratory
Study

3.1 Introduction
Symptomology following a motor vehicle crash (MVC), has been a well-documented
occurrence.1,2 Of these various symptoms, whiplash-associated disorders (WAD)
represent a common and burdensome problem from many different contexts including
social and personal costs.3 The symptoms of WAD can include but are not limited to:
neck pain, loss of range of motion of the neck, neurological deficits, and even fracture of
the cervical spine.4 However, despite the persistent issues associated with WAD,
consensus regarding its etiology is far less certain.5,6 Many theories have proposed that
the development of symptoms may be due to the biomechanical influences of the car
crash, such as the speed or direction of impact.5,7 Other competing theories have
suggested that the development of WAD in some cases is not due to biomechanical
influences, but rather psychosocial factors including maladaptive beliefs and/or an
exaggerated stress response to trauma.7,8 Unfortunately, many of these theories are
difficult to investigate empirically as it is simply not ethical to place individuals in live
car crashes nor has the manipulation of car crash parameters under controlled
circumstances been feasible.9
Accordingly, Virtual Reality (VR) has emerged as a technology through which otherwise
dangerous situations such as MVCs can be simulated without the risk of biomechanical
injury causing tissue damage.9 Recently, VR has been leveraged as a means to create pain
distraction, improve neck range of motion, and to engage adolescents in physical activity
through exergaming.10–12 VR is usually achieved through the combination of a headmounted display (HMD), head/limb tracking hardware, and a powerful computer to
create an immersive three-dimensional environment.13 The creation of an immersive
three-dimensional virtual environment can help to create a sense of presence in said
environment, which has been defined as the psychological sense of ‘being there’.14
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Traditionally, the sense of presence is amplified by enhanced virtual interactivity, greater
visual vividness, and multi-sensory input while it is diminished by feelings of simulator
sickness and an awareness of the apparatus being used.15,16
We have created an immersive Virtual Reality (VR)-based road traffic collision simulator
that also interfaces with a programmable 6 degrees of freedom robotic platform. While
other such driving simulators exist, (to our knowledge) ours is the first where a virtual
collision is the main intent.17,18 Also, while previous research has demonstrated the
effects of placebo car crashes in lab settings,5 ours was specifically created to immerse
participants in a scenario designed to imitate the settings of a real-world MVC and elicit
feelings of presence. A VR environment that is designed to mimic emotional or stressful
environments (i.e., MVC) may elicit greater feelings of presence, and thus may be more
appropriate to explore the sensation of involvement in a MVC than traditional laboratory
settings.19 MVC’s are considered to be a unique stressor in adult life, that can lead to
feelings of sudden chaos and a fear of safety, all of which may act as a catalyst toward
the development of WAD.7 Thus, the purpose of this study was to explore the tolerability
of using a VR road collision simulator, to gather user feedback for optimization, and to
examine the development of any adverse events (i.e., reports of neck pain longer than 48
hours, vomiting, inability to tolerate VR, disorientation). Exploration of development of
symptoms following exposure to the VR platform was also deemed relevant as previous
research has highlighted the possibility of symptom development following exposure to a
placebo car crash.5

3.2 Methods
This was a cross-sectional exploratory study with a pre-to-post design.
Participants
Healthy participants were recruited from the community via email and word of mouth at
Western University between October 2020 and January 2021. Eligible participants were:
18 years or older, otherwise healthy with no recent (3 months) significant trauma or
injury that required medical care and were able to read and understand conversational
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English. Exclusion criteria were recent neck pain, headache, concussion, cardiovascular
instability (e.g., heart disease, high or low blood pressure), were actively undergoing
cancer treatment, neurological or systemic conditions that affect balance or postural
control (e.g., Benign paroxysmal positional vertigo), migraines, visual pathology (e.g.,
saccades), technophobia, and claustrophobia. Subjects also had to pass a cervical
dysfunction clearing test performed by one of the primary investigators (M.J.L).
Secondary to the COVID-19 pandemic, participants also had to complete a standardized
questionnaire examining their suitability to return to campus and also had to have their
temperature checked and screened prior to participation. This study was approved by the
Health Sciences Research Ethics Review Board at Western University (London, ON,
Canada) prior to participation in the study and all participants provided written informed
consent prior to participation.
The VISION System
The VISION (Virtual Interface for Stress-Trauma Interactions through Open World
Navigation) system is comprised of a HTC Vive (HTC Corporation, Xindian City,
Taipei) head mounted VR display (HMD), noise cancelling headphones, and a Mikrolar
R3000 (Mikrolar Inc., Hampton, NH, USA) robotic platform. The virtual environment
these hardware peripherals interface with depicts a simulated car ride through a city. The
visuals of this simulation are delivered by the onboard screens of the HMD which also
tracks the participant’s head position via two fixed infra-red base stations, allowing the
participant to examine 360 degrees of their surroundings from the passenger seat of the
moving vehicle (Figure 2). To maintain a heightened sense of immersion, the
simulation’s audio is delivered by a set of noise-cancelling headphones such the volume
of all external audio sources is reduced, further emphasizing the sounds of the virtual
environment. Lastly, the simulation is designed such that the movements of the
participant’s virtual car are synchronized with a robotic platform which can be controlled
along six programmable degrees of freedom: the x-,y-, and z-planes as well as yaw, pitch
and roll (Figure 1). Prior to the collision, the robotic platform will simulate the feeling of
acceleration and deceleration by modulating its yaw, pitch, and roll to match that of the
virtual car. At the moment of impact, the VISION system also delivers a perturbation to
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its occupants based upon the type of crash selected (rear-end, side-impact, or front-end).
Instructions provided to the robot were designed to not accelerate beyond 1g for any of
the crash scenarios; for reference the head and neck experiences 1 to 3 g of acceleration
during sneezing.20 On pilot testing we determined that for the rear crash scenario the
peak accelerations at the head were no greater than 0.2 g. It should also be noted that the
cervical spine regularly experiences such accelerations (1 g) in daily life without
provoking symptoms.5
The VISION system is capable of 12 different crash scenarios, each of which can be
altered via the following crash parameters: the type of crash encountered (rear-end, sideimpact, or front-end), amplitude of perturbation (low or high), time of day (night or
dusk), weather (rain or clear skies), seat position (front passenger, or right/left rear
passenger), audio selection (no music or various musical selections), whether or not the
glass of the car shatters upon impact, and whether or not the participant receives audio
indication that a collision is to take place (e.g. lights and horn of colliding vehicle). For
the purpose of this initial exploration of tolerability to the system, participants were
exposed to a low speed rear-end collision at night under clear weather while they sat in
the front right passenger seat with no music playing. The windshield glass of the virtual
car was set to shatter and the participant received an audio indication that a crash was
imminent via a simulated car horn played through the earphones. These parameters were
selected as they were thought to be the least provocative in nature yet mirror those in
rear-end MVCs, for which development of whiplash injuries has been reported to be the
most common.21,22
Experimental Protocol
Prior to their visit with the research team, each participant completed a study-specific
demographic questionnaire indicating their sex and age. Each subject also completed the
state version of the State-Trait Anxiety Inventory-6 (STAI-6)23 to assess general anxiety
as well as the Fear of Pain Questionnaire–9 (FPQ-9)24 to assess fear of pain. The FPQ-9
is a shortened version of the FPQ-III which has demonstrated good psychometric
properties. The FPQ-9 consists of 9 items scored on a 5-point Likert-scale, with higher
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summed scored indicating higher fear of pain.24 The FPQ-9 also has three subscales
which can be calculated: Fear of Severe Pain, Fear of Minor Pain, and Fear of
Medical/Dental Pain.24 The STAI-6 consists of 6 questions measured on a 1 to 4 Likertscale and has been determined to provide similar results to that of the full 20-item
STAI.23 Each question is summed with higher scores signifying greater anxiety ranging
from a minimum of 6 to a maximum of 24. For comparison to norms, the total score was
divided by six, and multiplied by 20 to generate a pro-rated score from 20-80 as would be
obtained from the full version.25 STAI scores can be interpreted as ‘no to low anxiety’
(20-37), ‘moderate anxiety’ (38-44), and ‘high anxiety’ (45-80).26
For the hour before the study, each participant was advised to refrain from any eating,
drinking, or physical activity. After having their cervical spines screened, and sitting
quietly for five minutes, each subject sat in the VISION simulator during a non-crash
route for five minutes to become acclimatized to being in a virtual reality simulation and
to judge the immersion of the simulator. This non-crash route involved sitting in the front
right passenger of a virtual car with it making four turns around a city block with no
crash. Seat height of each participant was optimized to their respective height based on
personal preference, the time of day was set to night, and no in-simulator music was
playing. Each subject was allowed to survey their virtual environment as much as they
wished during the virtual drive. Following the five minute acclimatization period during
the non-crash route, subjects were given a minute of rest prior to the next simulation.
This rest period consisted of removal of the VR-headset, but participant remained in the
seated in the robotic platform. Immediately following the non-crash simulation, each
participant was informed that the subsequent simulation would include a virtual car crash
but were not told when or where (i.e., rear-end collision) it would transpire. Each
participant was then exposed to the low-speed rear end collision through the VISION
platform, that occurred after approximately 1 minute of simulated riding in the virtual
car. During the crash the robot delivered a small anterior perturbation (<1 g) to the
participant through the car seat to further the immersion of the simulation. Afterwards,
the participants dismounted from the simulator, and were observed for five minutes to
monitor for the presence of any immediate adverse events.
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Sense of Presence and Simulator Sickness
After this period each participant completed the Presence Questionnaire (PQ),27,28 and the
Simulator Sickness Questionnaire (SSQ)29 to gather initial feedback regarding the
immersion of the VISION simulator and to capture any adverse reactions. The PQ has 24
items from 1 to 7 on a Likert scale designed to measure the degree to which a participant
feels immersed or present in a virtual simulation. Each item from the Presence
Questionnaire is summed with higher scores representing greater immersion.27 The
individual items from the PQ can also be summed to produce summary scores in the
following categories: Realism, Possibility to act, Quality of interface, Possibility to
examine, and self-evaluation of performance.27 For the present study, questions 20 to 24
were pertinent to sounds and haptic and such were excluded from the study as they were
deemed not immediately relevant before study commencement. The 19-item version of
the PQ with a maximum score of 133 was selected over the original 32-item
questionnaire due in part to its shortened length and good internal consistency.27,28
The SSQ is a 16-item survey with responses ranked from 0 to 3 points.29 The 16
symptoms are placed into three categories (Oculomotor, Disorientation, and Nausea) with
unique weights attached and summed to produce a total score, with higher scores
indicating a greater degree of nausea with a maximum score of 235.62.29,30 Total scores
above 20 have been suggested to indicate ‘sufficient discomfort’.31 Each participant was
instructed to follow-up with the research team should they develop any adverse events
that lasted beyond 48 hours following the protocol.
Statistical Analysis
Descriptive statistics, including mean, standard deviation and range, were calculated for
participant demographics, STAI (pre and post-simulation), SSQ and PQ scores (as well as
their subscales). Data were visualized via box-and-whisker plots and outliers were
identified through visual and statistical tests of normality. The majority of the measures
were non-parametric in nature (Kolmogorov-Smirnov tests). Individual items from the
PQ and SSQ were critically examined independently in order to determine the usability
of the VISION platform and to ascertain areas for improvement. SSQ items were
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recorded as a percentage of the total sample to understand incidence for each of the
scores (i.e., none, slight, moderate and severe). As the PQ items do not have a descriptor
for each part of the scale, individual items were examined descriptively (mean + standard
deviation). Adverse events were recorded throughout the protocol as incident counts of
reported neck pain longer than 48 hours, immediate vomiting, inability to tolerate the
simulator, and self-reported disorientation post-protocol. A Wilcoxon-signed rank test
was used to examine differences in STAI-6 scores from before and after exposure to the
simulator. Spearman’s correlations were used to examine for relationships between SSQ,
STAI-6, FPQ, and PQ scores. Strength of Spearman correlations were interpreted as:
<0.30 (negligible), 0.30 to 0.50 (low), 0.50 to 0.70 (moderate), 0.70 to 0.90 (high), >0.90
(very high).32 All analyses were conducted using IBM SPSS Version 27, and the level of
significance was set at p<0.05.

Sample Size Calculation
As this research project was exploratory in nature, no formal sample size calculation was
performed, though a small sample of as little as 20 participants has been suggested as
appropriate for exploratory studies.33 A sample of 25 participants was deemed to be
sufficient in order to ascertain an initial impression of tolerance to the VISION simulator
and to determine to areas of improvement while minimizing risk of exposure to this
potentially provocative scenario.

3.3 Results
Participants
25 healthy participants (16 male, 9 female) with no recent (3 months) significant trauma
or injury that required medical care participated in the study. The mean age of the group
was 27.3 + 4.1 years (Table 5). All subjects successfully completed all aspects of the
protocol and there were no verbal reports of nausea, inability to tolerate VR, and
complete disorientation in response to the virtual simulation. There were no reports of
neck pain immediately after the simulation. One subject did report neck pain on the day
immediately after the virtual simulation but their symptoms only lasted one day. No
medical follow-up was required. Total FPQ-9 scores were similar to those reported in
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previous investigations into otherwise healthy participants.34 STAI-6 scores prior to the
simulation indicated ‘high anxiety’ prior to the simulation. There were no significant
differences between STAI-6 scores from before (46.53 + 6.05 ) and after (44.27 + 5.14)
the VISION simulator.
Simulator Sickness and Sense of Presence
Results for the Simulator Sickness Questionnaire and Presence Questionnaire and their
subscales (mean + standard deviation, range) are presented in Table 6. In terms of
Simulator Sickness, the mean total score was 23.49 + 21.98 (0.00 to 89.76) out of a
possible 235.62 indicating sufficient discomfort. The majority of participants indicated
none to slight for each item of the SSQ with twelve participants reporting moderate
severity of a number of symptoms including nausea and fatigue, and only one participant
indicating severe symptoms (eye strain) (Table 7). In terms of feelings of presence and
immersion, the mean of the total PQ score was 91.04 + 14.08 (54.00 to 112.00) out of a
possible 133. Participants rated the ability to control events (mean 2.04 out of 7.0),
environmental responsiveness (mean 3.4 out of 7.0) least favorably compared to the
remainder of the PQ items (mean 5.0 out of 7.0; Table 8).
Correlation Analysis
A significant low negative correlation (r=-0.40 to -0.49) was observed between the SelfEvaluation subscale of the PQ and the SSQ total score, as well as its Nausea and
Disorientation subscales. There was no significant correlation observed between the PQ
and SSQ total scores. There was a significant low negative correlation (r=-0.41 to -0.48)
between Post-simulation STAI-6 scores and SSQ total score, as well as its Nausea and
Disorientation subscales. A full description of the correlation analyses is presented in
Table 9.

3.4 Discussion
The purpose of this study was to explore initial user reactions to a novel virtual realitybased road collision simulator for empirical investigation into potential mechanisms of
WAD. We also sought to screen for the presence of any adverse events in reaction to the
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VISION simulator. Our study demonstrated that exposure to a VR-based MVC was well
tolerated by a majority of participants, although one participant reported neck pain the
following day, which did not last longer than 24 hours. There appeared to be a negative
relationship between sense of presence and simulator sickness, specifically between the
Self-evaluation subscale of the PQ and the SSQ total score as well as the Disorientation
subscale of the SSQ. This relationship may indicate that as a participants sense of
presence increases, they experience less feelings of simulator sickness.
One subject reported severe eye strain in reaction to the simulator; otherwise, the
simulator was well tolerated across all other items of the SSQ. The mean SSQ score was
23.49 + 21.98, which based on previous research, indicates ‘sufficient discomfort’.31
However, SSQ score interpretation has faced some contention as the cutoff score of 20.0
has been criticized as too strict in the context of non-aviation VR simulations, nor is it
recommended to interpret scores compared to the maximum possible score (235.62). 35
That being understood, as the majority of the items on the SSQ were rated as ‘None’ or
‘Slight’, we are reasonably confident that we can conclude that the VISION platform was
tolerated well enough. There were no adverse events recorded in reaction to the
simulator, allowing us to conclude that the use of VR-based road collision simulator can
be safely used to simulate rear-end MVCs in a controlled fashion.
One of the 25 participants (4%) in the present study reported neck pain following
exposure to the novel VR-based MVC. We are confident in saying that this was not due
to the perturbation delivered by the VISION platform, as the peak accelerations were
magnitudes lower than those encountered in daily life. The peak accelerations of the
VISION platform were also lower than that of those reported by Fice et al. (2019) who
simulated laboratory based rear-end collisions without VR with peak accelerations of
2.1g seemingly without incident.36 However, this finding of neck pain stands in stark
contrast to the findings of Castro et al. (2001), who found that approximately 20% of
their sample developed whiplash like symptoms in exposure to a placebo car crash.5
There could be multiple explanations for this finding. In our study, one explanation is that
participants were aware that the VISION platform was a simulator, and in essence a
video game compared to the real world objects were used to provide a placebo car crash
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in the study by Castro et al. (2001).5 However, as VR has been previously used
successfully to treat posttraumatic stress disorder following a MVC,18,37 it appears that
VR is able to replicate near-real virtual representations of traumatic scenarios.38 While
the present study was not able to effectively confirm the development of WAD in
reaction to a VR-based MVC, it also is not able to refute the theory either. Future work is
needed to clarify the development of WAD-like symptoms from simulated collisions.
While our PQ total score (68.4%) was lower than the clinically acceptable amount for
VR-based driving simulators for VR-based exposure therapy (80%), we believe that with
further refinement PQ scores will improve which may lead to higher incidences of selfreported neck pain and/or other symptoms.39 Another possible explanation for the
discrepancy between our findings and that of Castro and colleagues is that the sample in
our study was much more limited than Castro et al. (2001).5 The psychological profile of
our sample was limited to university students aged 18-35 and may not have included
participants with a higher tendency for psychosomatic disorders who may be a higher risk
for WAD-like symptoms from a simulated MVC without biomechanical potential for
injury.5
As the VISION platform is a prototype for simulation of MVCs, visual fidelity of the VR
may be partially to blame for the lower-than-desired presence scores. There were
occasional visual ‘skipping’ or ‘lag’ episodes where the framerate of the virtual display
would drop to an unrealistic level. These episodes may explain why subjects rated the
responsiveness of the virtual environment lower on the PQ but are expected to improve as
the framerate of the VISION platform is optimized. These issues may also partially
explain the statistically unchanged STAI-6 scores from pre- to post- exposure. As higher
levels of anxiety have been associated with increased presence,40 it stands to reason that
as the visuals and responsiveness of the VISION platform improve, STAI scores post
exposure should also reflect greater anxiety. It should also be noted that this line of
research was conducted during the COVID-19 pandemic, and as such there may have
been influences on baseline levels of stress and/or anxiety that we could not control for.
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There appeared to be an inverse relationship between both the sense of presence and
simulator sickness as measured by the PQ and SSQ. This finding is in agreement with the
findings of Weech and colleagues who conducted a scoping review in 2019, concluding
that a majority of the available literature favors a negative relationship between the sense
of presence and simulator sickness.41 However, these authors did conclude that this
relationship is likely mediated by several factors such as sex, personality type, and
previous gaming experience (for which we did not control). Lastly, oculomotor
dysfunction can be one finding of WAD, even in patients who do not report symptoms.42
As simulator sickness has been characterized by a predominance of oculomotor
symptoms,41,43 it is unclear if simulator sickness is a prognostic indicator for those most
likely to develop WAD. As such, further investigation will be required to explore how
high SSQ scores in otherwise healthy people may relate to the development of WAD
following exposure to a simulated MVC.
Limitations
The sample size of this exploratory study was small and as such its conclusions must be
interpreted with caution. However, this study sought to seek initial responses to a novel
virtual car collision simulator and sought to explore initial reactions and the presence of
adverse events. As such, we believe we were successful in this endeavor and that the
results of the study will help to inform larger study designs in order to answer additional
questions. Another limitation with this work is that we did not control for multiple
comparisons as the work was preliminary in nature. However, we feel that due to the
exploratory nature of the research the results still hold merit and invite future
investigation. As mentioned earlier, we also did not control for subjects with previous
virtual reality experience nor did we control for participants who had been involved in
previous car crashes. Both of these variables could influence the sense of presence and/or
simulator sickness in response to the VISION platform. That being said, the results of our
study are in agreement with previous literature highlighting a negative relationship
between simulator sickness and presence.
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Additionally, there were rare occurrences of the base stations losing track of the
participant’s head in 3-D space. As a result, the system had to be re-set in order to retrack the participant’s location. These tracking errors may have led to lower feeling of
presence during the simulation. Again, with further refinement, it is expected that that the
incidence of these episodes should be greatly reduced. The framerate of the VISION
system also requires optimization. Lower frame rates could partially explain feelings of
simulator sickness. Participants were also made aware that a collision would occur which
may have influenced their reaction to the simulator. Lastly, we only used a small sub-set
of the VISION platform’s settings. As such, it is unclear how the other settings (e.g.,
direction of impact, in-simulation music, awareness of impending collision) may impact
stress, the sense of presence, and simulator sickness.

3.5 Conclusion
In conclusion, we have successfully created a virtual-reality based road collision
simulator that is capable of simulating motor vehicle crashes under a controlled fashion
for lab-based research. There were no adverse events, and all participants tolerated the
VISION system well despite one participant reporting neck pain the following day. It
appeared that the sense of presence may be negatively associated with simulator sickness.
Sense of presence was not as high as we would have hoped, and opportunities for
improvement include improvement of framerates to increase the responsiveness of the
simulator, and better tracking of the HMD used in the simulator. Future research should
examine the effects of combining simulator settings (e.g., front end collision with no
audio warning) in order to explore adverse effects and the sense of presence.
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Table 5. Baseline Participant demographics. Data are presented as mean + standard
deviation with range in brackets.
Total
Sample Size (%female)
Age

25 (36%)
27.3 + 4.1 (18-35)

FPQ Total Score

18.88 + 4.41 (10.00 to 27.00)

FPQFear of Severe Pain

9.20 + 2.43 (4.00 to 14.00)

FPQFear of Minor Pain

4.64 + 1.35 (3.00 to 8.00)

FPQFear of Medical/Dental Pain

5.04 + 1.76 (3.00 to 8.00)
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Table 6. Simulator Sickness Questionnaire and Presence Questionnaire results post
simulation including subscales. Data are presented as mean + standard deviation
with range in brackets.

Total
SSQnausea

17.55 + 19.80 (0.00 to 85.86)

SSQoculomotor

19.71 + 19.08 (0.00 to 45.48)

SSQdisorientation

22.27 + 26.07 (0.00 to 97.44)

SSQtotal

22.59 + 21.98 (0.00 to 89.76)

PQRealism

33.28 + 6.69 (17.00 to 42.00)

PQPossibility to act

15.36 + 4.48 (7.00 to 22.00)

PQQuality

16.48 + 3.71 (6.00 to 21.00)

PQPossibility to examine

14.44 + 2.97 (10.00 to 20.00)

PQSelf-evaluation of performance

10.96 + 2.37 (5.00 to 14.00)

PQTotal

91.04 + 14.08 (54.00 to 112.00)
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Table 7. Simulator Sickness Questionnaire individual items analysis. Data are
presented as percentages reported by total sample.
Symptoms

None

Slight

Moderate

Severe

General Discomfort

56%

40%

4%

-

Fatigue

76%

16%

8%

-

Headache

72%

28%

-

-

Eye Strain

56%

36%

4%

4%

Difficulty Focusing

60%

40%

-

-

Salivation Increase

92%

8%

-

-

Sweating

80%

20%

-

-

Nausea

68%

24%

8%

-

Difficulty Concentrating

60%

40%

-

-

Fullness of Head

80%

20%

-

-

Blurred Vision

84%

16%

-

-

Dizziness (Eyes open)

76%

20%

4%

-

Dizziness (Eyes closed)

92%

4%

4%

-

Vertigo

96%

4%

-

-

Stomach Awareness

76%

20%

4%

-

100%

-

-

-

Burping
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Table 8. Presence Questionnaire individual items analysis. Data are presented as
mean+ standard deviation. Each item was rated from 1 to 7, with higher scores
representing increased immersion, but items 14, 17, and 18 are reversed.
PQ Item

Mean Score + SD

1. How much were you able to control events?

2.04 + 1.40

2. How responsive was the environment to actions that you initiated (or performed

3.40 + 1.85

3. How natural did your interactions with the environment seem?

4.46 + 1.23

4. How much did the visual aspects of the environment involve you?

4.32 + 1.34

5. How natural was the mechanism which controlled movement through the environment?

4.60 + 1.26

6. How compelling was your sense of objects moving through space?

5.04 + 1.14

7. How much did your experiences in the virtual environment seem consistent with your real world experiences?

4.76 + 1.16

8. Were you able to anticipate what would happen next in response to the actions that you performed?

4.00 + 1.91

9. How completely were you able to actively survey or search the environment using vision?

5.92 + 0.86

10. How compelling was your sense of moving around inside the virtual environment?

5.08 + 1.08

11. How closely were you able to examine objects?

4.64 + 1.38

12. How well could you examine objects from multiple viewpoints?

3.92 + 1.58

13. How involved were you in the virtual environment experience?

5.20 + 1.22

14. How much delay did you experience between your actions and expected outcomes?

5.42 + 1.32

15. How quickly did you adjust to the virtual environment experience?

5.32 + 1.49

16. How proficient in moving and interacting with the virtual environment did you feel at the end of the experience?

5.64 + 1.19

17. How much did the visual display quality interfere or distract you from performing assigned tasks or required

5.32 + 1.46

activities?
18. How much did the control devices interfere with the performance of assigned tasks or with other activities?

6.21 + 0.93

19. How well could you concentrate on the assigned tasks or required activities rather than on the mechanisms used to

5.88 + 0.97

perform those tasks or activities?
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Table 9. Spearman correlations between STAI-6 (Pre & Post), FPQ, PQ, and SSQ (as well as their subscales).
Pre STAI-6

Post-STAI-6

FPQ-9

PQRealism

PQPossibility

PQQuality

SSQdisorientation

SSQtotal

-

0.35

0.10

0.02

-0.240

0.03

0.12

-0.24

-0.03

-0.18

-0.12

-0.09

-0.12

-

0.13

0.06

-0.28

0.11

0.11

0.20

0.01

-0.48*

-0.37

-0.41*

-0.46

-

-0.20

-0.35

-0.19

-0.19

-0.22

-0.34

-0.02

-0.18

0.00

-0.07

PQRealism

-

0.37

0.36

0.65**

0.63**

0.86**

-0.34

-0.22

-0.20

-0.27

PQPossibility to Act

-

-

-0.14

-0.01

0.32

0.45*

0.02

0.11

0.01

0.06

PQQuality

-

-

-

0.51**

0.18

0.58*

-0.13

-0.08

-0.01

-0.02

PQPossibility to Examine

-

-

-

-

0.31

0.60**

-0.12

-0.02

-0.06

-0.08

PQSelf-Evaluation

-

-

-

-

-

0.60**

-0.49*

-0.32

-0.40*

-0.46*

PQTotal

-

-

-

-

-

-

-0.34

-0.03

-0.1.6

-0.17

SSQNausea

-

-

-

-

-

-

-

0.75**

0.68**

0.90**

SSQOculomotor

-

-

-

-

-

-

-

-

0.69**

0.92**

SSQDisorientation

-

-

-

-

-

-

-

-

-

0.84**

SSQTotal

-

-

-

-

-

-

-

-

-

-

to Act

Pre STAI-6
Post-STAI-6
FPQ-9

PQPossibility to

PQSelf-

Examine

Evaluation

STAI-6: State and Trait Anxiety Inventory – 6, FPQ-9: Fear of Pain Questionnaire -9, PQ: Presence Questionnaire, SSQ: Simulator Sickness Questionnaire

* Significance at p<0.05; **Significance at p<0.01

PQTotal

SSQNausea

SSQoculo
motor
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Chapter 4

4

Changes in Heart Rate Variability, Pressure Pain
Threshold and Salivary Cortisol After Exposure to a
Novel Virtual Reality-Based Motor Vehicle Crash

4.1 Introduction
The impact of whiplash-associated disorders (WAD) following a motor vehicle crash
(MVC) are substantial, with both burden on the healthcare system and numerous personal
costs.1 The symptoms of WAD vary, but commonly include both physical symptoms
(e.g., neck pain) and psychological symptoms (e.g., post-traumatic stress disorder), often
co-occurring.2 Despite its evident global burden, debate over the mechanisms for the
development and maintenance of WAD has persisted, especially for the transition from
acute to chronic symptomology.3,4 Previous literature has suggested that direction and
speed of impact do not correlate with poor recovery,5 while other novel models of WAD
have proposed that its development may be due to a dysregulated or maladaptive stress
response to trauma.3,6
In this context, the stress/startle reaction is considered any physiological change that
indicates an increased sympathetic: parasympathetic tonal balance. In practice, this could
be a sudden increase in somatic neuromuscular activity, change in heart rate, heart rate
variability (HRV), or increased endocrine activity to protect against potential injury.7
Autonomic dysregulation (i.e., sympathetic nervous system dominance) has been
suggested as a further clinical feature of WAD and other persistent conditions (e.g.,
Concussion), for which there is symptom overlap.1,6,8 Endocrine abnormalities in the
form of reduced cortisol reactivity have been implicated in patients with chronic WAD
compared to healthy controls.9 Cortisol is a glucocorticoid hormone that is released in
reaction to a stressor that aids with the restoration of homeostasis.10,11 Previous research
has indicated a negative association between pain perception and cortisol levels,
suggesting that increased pain sensitivity was found in participants with higher cortisol
(Choi, 2012).10 HRV has also emerged as an objective measure for psychological stress,
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as it provides non-invasive indication of both sympathetic and parasympathetic control of
the body.12
Autonomic dysregulation following a MVC has also been suggested to be related to pain
inhibition.6,13 Decreased pressure pain detection threshold (PPDT) (or higher sensitivity
to pain) locally at the neck has been reported in patients with both acute and chronic
WAD, as well as impaired ability to modulate pain in the presence of a noxious stimulus,
a process known as Conditioned Pain Modulation (CPM).13,14 Typically, a decrease in
sensitivity to one pain stimulus (e.g. mechanical pressure) after exposure to a different
‘conditioning’ stimulus (e.g. noxious cold) is classified as having experienced inhibition,
while an increased sensitivity indicates facilitation.15 In other words, inhibition of PPDT
represents an increase in pain threshold as measured by PPDT, while facilitation
represents a decrease in PPDT. CPM is considered a quantifiable psychophysical test of
nociceptive processing and has seen increasing use in pain research and practice owing to
prior literature indicating that the nociceptive modulation is less effective, or perhaps
even reversed (i.e., increased sensitivity to the testing stimulus after conditioning) in
some chronic pain conditions.16 However, it is also unclear of exactly when increased
pain sensitivity arises after trauma (i.e., immediately after or delayed onset) as sensory
hypersensitivity has typically been investigated up to five weeks post-injury.17
To date, the mechanisms of WAD have remained unclear, as previous longitudinal
research has been forced to adopt an observational approach (as opposed to experimental)
in order to understand what types of individuals develop conditions such as WAD.3,18 As
a result, innovative research design has been called for to better assess the role of
proposed theoretical models.3 Recently, we have developed a novel Virtual Reality (VR)
and robot-based road collision simulator (see Chapter 3) designed to mimic the
participant’s perspective of being involved in a MVC, without the potential for tissue
damage from biomechanical forces. As a result, we are now poised to measure the
physiological effects of VR-based MVC in real-time on healthy participants. Thus, the
purpose of this study was to explore aspects of the physiological response to a novel
Virtual Reality-based road collision simulator, using quantitative sensory tests (PPDT)
and indicators of stress system reactivity such as heart rate variability (HRV) and salivary
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cortisol. We also aimed to explore the use of the novel VR MVC simulator as a
conditioning stimulus to examine its effects in eliciting a CPM response and any
associations between the change in stress reactivity metrics and CPM.

4.2 Methods
Study Design
This was an exploratory cross sectional study with a repeated measures design.
Participants had baseline levels of PPDT, HRV, and salivary cortisol before and after
exposure to VR-based MVC as described below. CPM was evaluated using a pre-to-post
design for which the simulated collision was the conditioning stimulus.
Participants
A convenience sample of healthy adult participants was recruited via email and word of
mouth at Western University between October 2020 and January 2021. Participants were
eligible for participation if they were: 18 years or older, otherwise healthy with no recent
(3 months) significant trauma or injury requiring medical care and could read and
understand conversational English. Potential participants were excluded if they reported
any pre-existing neck pain, headache, concussion, cardiovascular instability, active
cancer treatment, neurological or systemic conditions that affect balance or postural
control (e.g., Benign paroxysmal positional vertigo), migraines, visual pathology (e.g.,
saccades), technophobia, and claustrophobia. Secondary to the COVID-19 pandemic,
participants also had to clear a standardized questionnaire examining suitability to return
to campus and had their temperature screened prior to participation. This study was
approved by the Health Sciences Research Ethics Review Board at Western University
(London, ON, Canada) prior to participation in the study and all participants provided
written informed consent prior to participation.
Experimental Protocol
Participants were asked to refrain from any strenuous physical activity and to avoid
consumption of any food or drink (including caffeine) for the hour prior to data
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collection. Participants completed a study-specific demographic questionnaire including
details such as sex and gender identity. A three-lead set-up was used to capture the
electrocardiogram (ECG) and the participants had the option of placing the electrodes
(200 Foam Series, Cardinal Health) themselves using a figure for reference or the option
of one of the primary investigators placing the electrode for them. After application of the
sensors, participants sat quietly for five minutes in a comfortable chair in a climatecontrolled windowless room while HRV was continuously captured by proprietary
computer software. Conditions in the lab were maintained as consistently as possible
across participants and testing days (lighting, temperature, noise, etc.). HRV5min was
evaluated, as five minute recordings are considered the minimum essential length of time
for evaluation of HRV.19 During data collection of HRV, participants were asked to avoid
talking or moving and to breathe otherwise normally. HRV was measured simultaneously
using ADInstruments PowerLab (PowerLab®, ADInstruments, Sydney, Australia) at a
sampling rate of 1000 Hz, with real time digitized and filtered data stored on a laboratory
laptop.

One saliva sample was collected near the end of the 5 minute rest period using a small
poly-cotton swab that was rolled around inside the mouth for about 30 second before
being sealed in a sterile salivette and immediately transferred to a -30C freezer. Next,
pressure pain detection threshold (PPDT) was tested at the angle of the upper trapezius
following a previously published protocol.20 In brief, the 1cm2 rubber tip of a digital
algometer (FDX-25, Wagner Instruments, Greenwich CT) was pressed into the skin over
top of the upper trapezius of the dominant side of the participant at a constant rate of 5N/s
until they indicated that the sensation changed from pressure to pain. This was repeated
three times, with a minimum 30 seconds between applications and the same rater
conducted each test (MJL). The mean of the three trials (measured in kilograms of force
(kgf)) was considered the PPDT.

Each participant was then assisted into the VISION (Virtual Interface for Stress-Trauma
Interactions through Open World Navigation) platform. A thorough description of the
VISION platform is in Chapter 3 of this thesis. The VISION platform consists of a seat
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affixed to a six degree of freedom robotic platform ((Mikrolar R3000 (Mikrolar Inc.,
Hampton, NH, USA)), a HTC Vive head mounted display (HTC Corporation, Xindian
City, Taipei) with active noise cancelling headphones. During its use, subjects were first
exposed to five minutes of driving in a virtual city as the passenger in the front seat of a
virtual vehicle in an urban setting at dusk where they were able to view their environment
as much as they wished but could not control the direction of speed of the vehicle. They
were then given one minute of rest. The robotic platform was programmed to interface
with the virtual reality headset such that movements of the virtual car were synchronized
with the robot’s movements to add a proprioceptive experience to the visual and audio
stimuli of being in a car. Subsequently, each participant was informed that the next
simulation would have a virtual car crash but were not told when or where it would take
place. In brief, subjects were exposed to a virtual reality based rear end collision that
delivered a perturbation at a peak acceleration of 0.2 g (measured at the head) that
coincided with the visual and audio indications of a rear end collision in the simulator
(i.e., a second car approached and collided from the rear while the participant vehicle was
stopped at a traffic light). Audiovisual stimuli included shattering glass of the windshield,
squealing tires, a simulated car horn just before and after the collision, and no music was
playing on the virtual car radio.

Following exposure to the virtual collision, participants were assisted out of the VISION
platform and the ECG leads were re-applied to their torso in the same fashion as the
baseline measurements; the electrode placement remained unchanged. Participants sat
quietly for 30 seconds prior to the re-evaluation of PPDT. PPDT was then measured
immediately after exposure to the VISION platform serially in the same fashion as the
pre-test for evaluation of any change. HRV was captured continuously throughout the
post-exposure resting period for off-line analysis of recovery. At the 5-minute postremoval point, one more saliva sample was collected using the same poly-cotton swabs
for post-exposure salivary cortisol. Each participant was also asked to return three to
seven days later to recapture only the resting baseline PPDT and HRV. Salivary cortisol
was not re-evaluated on the re-test day.
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Statistical Analysis
Descriptive statistics including mean and standard deviation of the sample were
calculated for each variable after normality was assessed using Kolmogorov-Smirnov
tests. Outliers were removed and ratio level data were transformed if necessary, using
logarithmic transformation. Data were presented in their un-transformed state to allow for
easier comparison to the greater body of literature.

HRV was analyzed over the five minute baseline period prior to the CPT and two five
minute bins after (post-exposure and resting-state retest three to seven days later). A
variety of HRV indices were selected in order to evaluate those best poised for further
investigation in future studies. HRV indices were reported in Time domain parameters
including root mean square of successive NN interval differences (RMSSD) and the
standard deviation of the RR intervals (SDRR). For the frequency domains, HRV was
analyzed with a high frequency (HF) band from 0.15 to 0.45 Hz and a low frequency
band from 0.04 to 0.15Hz. HF and LF were both measured in absolute (us2) and
normalized units (nu), as per the recommendations from the Task Force of The European
Society of Cardiology.21 The ratio of LF/HF was also calculated, whereby a higher ratio
indicates sympathetic dominance, and a low ratio indicates parasympathetic dominance.19

Physiological Reactions to VISION Platform
For purpose 1 (normative reactions to the VISION platform), mean PPDT and HRV were
compared across testing times (T1 = 5 minute pre-simulation, T2 = 0-5 minute postsimulation, and T3= 5 minutes retest 3 to 7 days later) using one way repeated measures
analysis of variance (rmANOVA) with Bonferroni post-hoc to further explore significant
main effects of time. Salivary cortisol (Cortisol (Saliva) ELISA, Alpco (Salem, NH,
USA), cat no.11-CORHU-E01-SLV) was analyzed using industry standard approaches
according to the manufacturer’s specifications and all samples were run in duplicate.
Salivary cortisol was evaluated using the absolute difference before and after the
exposure to the VR-based MVC to account for individual variation and a paired t-test was
used to detect for significant differences. A logarithmic transformation was applied to
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HFms and LFms, as all other measurements were found to be normally distributed for
parametric statistics.
CPM Response
For purpose 2, (CPM responses) CPM was recorded in both absolute (∆CPMABSOLUTE =
Post - Pre simulation (in kgf)) and percent (%) change ((∆CPMPERCENT =
∆CPMABSOLUTE/Baseline PPDT(kgf) x100)) terms, as per the recommendations of
Kennedy et al., 2016.16 Meaningful CPM was evaluated using a similar approach was
used to the work of Locke et al. 2014 and Kennedy et al., 2020.15,22 Next, the standard
error of measurement (SEM) was calculated for PPDT ((SEM = pooled standard
deviation of baseline PPDT (SDpooled)√(1-ICC)). Based on the work of Kennedy et al.,
2020, CPM was examined in relation to +2 SEM of baseline PPDT to reflect a 95%
confidence interval in order to determine true change.15 This was then converted a
percentage change based upon baseline mean PPDT. Both a percentage change and
absolute change were included to reflect participants who may have experienced a small
absolute difference, but large percent change compared to baseline testing.
Relationship between CPM and Stress System Reactivity
For purpose 3 (associations between CPM, change in HRV and salivary cortisol)
Pearson/ Spearman correlations were used to explore the relationship between CPM,
itself a metric of change, and change in the various HRV indices. Associations were
explored with all HRV indices in order to target the ones best positioned for future
studies. Strength of Pearson/Spearman correlations were interpreted using the
recommendations of Mukaka (2012), whereby: <0.30 (negligible), 0.30 to 0.50 (low),
0.50 to 0.70 (moderate), 0.70 to 0.90 (high), >0.90 (very high).23 Scatter plots were also
used to both visually model and interpret the relationships of the data.
All statistical analyses were completed using IBM SPSS Statistics Version 27 and the pvalue for statistical significance was set at 0.05.
Sample Size Calculation
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As this work was hypothesis-generating rather than hypothesis-testing, no formal sample
size calculation was performed.

4.3 Results
Descriptive Statistics
25 participants (16 males, 9 females) participated in the study and no participant in the
study indicated their sex as different from their identified gender. As such, only male and
female sexes are reported. The mean age was 27.3 + 4.1 (18 to 35) years. Demographics
of the study population are displayed in Table 10. There was no attrition, as all
participants returned for re-evaluation of their baseline measurements on the second
testing day.

Physiological Reactions to VISION Platform
In terms of the time domain measures of HRV, RMSSD was significantly increased
(p<0.002) after exposure to the VISION platform from 39.80 + 17.08 ms (95%CI: 32.75
to 46.85ms) to 48.63 + 19.40ms (95%CI: 40.44 to 56.82). For the frequency domains,
absolute high frequency power was significantly increased (p=0.004) from 900.96 +
766.95 ms2 (95%CI: 33.22 to 47.68) to 1262.96 + 853.38 ms2 (95%CI: 893.93 to 1631.99
ms2) after exposure to the VISION platform. Absolute low frequency power was also
significant increased (p=0.004) after the VR-based MVC from 1534.42 + 1251.07 ms2
(95%CI: 993.41 to 2075.42 ms2) to 2108.87 + 1332.82 ms2 (95%CI: 1558.71 to 2659.03
ms2). All other HRV indices at each time point are displayed in Table 11. There were no
significant differences in any HRV measurement upon retest approximately one week
later compared to baseline. Baseline values of PPDT were 3.36 + 1.14 kgf (95% CI: 2.89
to 5.80 kgf) with no significant differences in values immediately after the VR MVC, or
three to seven days later upon re-test. See Table 11 for a full description of PPDT values
at these time points. Baseline levels of salivary cortisol were 31.57 + 13. 95 ng/mL (95%
CI: 24.39 to 38.74 ng/mL) with no significant differences after exposure to the VR-based
MVC. Cortisol data were only available on 17 participants because of COVID-19 related
interruptions during the study period.
CPM Response in reaction to VISION platform
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When assessed as a group mean, CPMABSOLUTE was found to be -0.24 + 0.68 kgf (95%
CI: -0.52 to 0.04 kgf) while CPMPERCENT was found to be -8.57% + 22.40 % (95%CI: 17.82 to 0.68%) after exposure to the VISION platform. The reliability of PPDT in the
present study was measured using intraclass correlation coefficient (ICC3,1) and was 0.96.
For this study, SEM of the baseline PPDT measurements was 0.23 kgf. Thus, it was
determined that based on +2 SEM of PPDT any change in PPDT greater than + 0.47 kgf
(or +13.9% of baseline mean PPDT) reflected inhibition, less than -0.47 kgf (or -13.9%
of baseline mean PPDT) reflected facilitation, and in between these values reflected nonresponse. After classification based on meaningful change of CPM >+ 2 SEM, it
appeared that 16% (4/25) of participants experienced inhibition of their pain threshold,
44% (11/25) experienced facilitation of their pain threshold, with the remainder
experiencing no appreciable change. See Table 12 for a description of CPM within these
groups. Using the CPM classification criteria, 16% (4/25) of participants still had a
noticeably decreased PPDT compared to their baseline measurements one week prior
upon re-test.
Associations between CPM and Stress System Reactivity
There was a statistically significant negative low correlation (r= -0.41, p=0.046) between
CPMPERCENT and ∆RMSSD before and after exposure to the VR-based MVC (Figure 4).
There was also a statistically significant negative moderate correlation (r= -0.64,
p<0.001) between the ∆HF(ms2) and CPMPERCENT (Figure 5). Taken together, it appeared
that that a decrease in pain thresholds (facilitation) was associated with an increase in
parasympathetic nervous system activity. See Table 13 for a full description of the
correlational matrix.
There was a moderate negative correlation between CPMABSOLUTE and pre-post simulator
change in salivary cortisol (r = -0.51, p = 0.035) (Figure 6). The association was
maintained for CPMPERCENT (r = -0.59, p= 0.03) (Figure 7) reflecting that a decrease in
pain threshold (facilitation) was associated with increased cortisol levels.
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4.4 Discussion
The purpose of this study was to explore the range of physiological reactions after
exposure to a novel VR-based MVC. We also explored the use of such a simulator in
determining its suitability as a potential CPM protocol. Our study demonstrated that
when analyzed as a group, while there was no significant changes in PPDT, there was a
statistically significant increase in HRV indices (RMSSD, absolute HF, absolute LF)
suggestive of an increase in parasympathetic nervous system post-exposure to a VRbased MVC. This increase in parasympathetic nervous system activity appeared to be
associated with greater sensitivity to mechanical pain (decreased pain thresholds). There
was also a significant moderate negative association between CPM and change in
salivary cortisol. When meaningful CPM was assessed as a change of PPDT greater than
+ 2 SEM, it appeared that 44% of participants experienced actual facilitation (i.e.,
decrease) of their pain threshold in response to the VISION platform. Approximately one
week later, up to 16% of participants continued to have a noticeably decreased PPDT
measurement compared to their baseline levels.
We were unable to demonstrate any autonomic system dysregulation following exposure
to the VR-based MVC in the present study as evidenced by the non-significant changes in
LF/HF. Baseline RMSSD values were within reported normative values from the
literature.24 HRV indices were similar to those of baseline values post-exposure, however
a statistically significant increase in parasympathetic nervous system activity was noted
after exposure to the simulated collision. Previous investigations into the relationship
between the autonomic nervous system and pain perception generally reflect that there is
an increase in sympathetic nervous system activity associated with decreased pain
sensitivity during an acute stressor – physical or mental.13,25,26 Unfortunately, due to the
wired configuration of the ECG we used, we were unable to measure the effects of the
VISION platform at the time of the virtual collision as the leads had to be removed to
allow the participant to enter the simulator.
We observed a low to moderate negative relationship between the percent change of
CPM and change in HRV values measurement reflective of parasympathetic system
activity after exposure to the VR-based MVC. Other studies have also investigated the
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relationship between autonomic reactivity and CPM to various degrees, however most of
these studies examine the relationship to resting HRV values. De Kooning et al., (2013)
found no significant correlations between CPM values and HRV indices and concluded
that autonomic reactivity and CPM appear to be unrelated.13 However, these authors did
not explore the change in HRV as it relates to CPM which may explain the dissonance in
findings. Koenig and colleagues (2016) did find a negative relationship between selfreported pain and resting RMSSD values in healthy participants as opposed to chronic
pain cohorts.27 Similarly, Nahman-Averbuch and colleagues (2016) also reported a
negative correlation existing between CPM and resting HRV (measured with RMSSD)
adaptations in men, but not women using tonic heat as a conditioning stimulus.28 Thus,
there may be sex-related differences in the relationship between CPM and autonomic
reactivity, however we were not sufficiently powered to explore this area. Sex-related
differences in autonomic reactivity as it relates to CPM requires further investigations,
especially given that WAD appears to affect a higher number of females than males.29
Nonetheless, our study is not the first to report increased parasympathetic nervous system
activity during recovery after exposure to an acute stressor. Mezzacappa and colleagues
(2001) reported that in reaction to a mental stressor, healthy participants experienced a
compensatory increase in RMSSD activity during recovery (also known as vagal
rebound) that they postulated might be needed to recover from stress.30 Rat studies have
also confirmed that exposure to repeated psychophysical stress leads to vagal rebound
lasting beyond the duration of the stressor.31 However, other authors have suggested that
while initial vagal rebound may be protective, prolonged exposure to stress may
eventually elicit a maladaptive phase of parasympathetic withdrawal and sympathetic
dominance.32 This speculation may also apply to individuals who are suffering from
chronic WAD, as sympathetic dominance has been suggested to be a causal factor in the
development of chronic pain.6,33 Mezzacappa and colleagues (2001) also suggested that a
lack of or impaired vagal rebound following a stressor may reflect a failure of the
parasympathetic nervous system to react, potentially increasing the risk for illness.30
Given the various psychosocial stressors that can arise after a MVC (i.e., insurers,
lawyers, and medical services),3 further research is needed to evaluate when and how
parasympathetic recovery is altered following exposure to an MVC.
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An interesting finding from this study was that there was a significant negative moderate
association between CPM (absolute difference or percent change) and the change in
salivary cortisol in reaction to the VR-based MVC. As a group, salivary cortisol was not
significantly different after the VR-based MVC, but this may reflect that cortisol
reactivity follows different patterns individually in reaction to a stressor. An explanation
for the non-significant increase in salivary cortisol levels may be that we evaluated it too
soon, as salivary cortisol levels have been known to peak after 10 to 20 minutes.34 Other
authors have also examined for the relationship between CPM and salivary cortisol in
healthy subjects. Timmers and colleagues (2018) found a positive correlation (r = 0.34)
between change in PPDT and salivary cortisol using the Maastricht Acute Stress Task
(combination of cognitive and physical stress) as a stressor.34 However, Hoegh and
colleagues (2020) who also found a negative correlation between the change in salivary
cortisol and PPDT using a cognitive Montreal Imaging Stress Test as a conditioning
stimuli, whereby the change in cortisol could explain 19% of the variance in PPDT
values.35 While we did not evaluate the role of cortisol in predicting PPDT values, it
appears that elevated cortisol immediately after a mental stressor may be associated with
decreased ability to modulate pain.35 Of course, due to mixed findings in the literature, it
is likely that this relationship is dependent on the type of conditioning stimuli used.
Larger studies will be required to investigate cortisol reactivity within meaningful CPM
to further explore these relationships.
Baseline PPDT values were higher than in previous investigations, possibly representing
that the participants in the current study experienced some degree of hyposensitivity, and
the SEM of baseline PPDT in the present study was similar to previous descriptions of
PPDT in healthy participants.20,36 However, as baseline measurements of PPDT were the
average of three measurements, we feel that regression to the mean cannot fully explain
the change in PPDT values. Most interesting was that just over 40% of the participants
included in this study had increased pain sensitivity of their trapezius muscles after
exposure to the VISION platform. Thus, unlike a majority of CPM protocols, the protocol
used in the present study did not encourage inhibition of pain thresholds, possibly
indicating that it is likely not appropriate as a conditioning stimulus in CPM protocols.16
However, there has also been debate over whether or not the conditioning stimulus in a
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CPM protocol needs to be noxious in nature to produce modulation of pain thresholds.37
For example, exposure to a mental conditioning stimulus (e.g., arithmetic counting) has
also been shown to lead to pain inhibition.25 Most recently, Kennedy and colleagues
(2020) evaluated the role of a sham conditioning stimulus (tepid water) in eliciting a
CPM response in healthy participants.15 They also found that over 40% of their subjects
experienced facilitation of their pain thresholds after exposure and concluded that
expectation of pain may have contributed to this effect.15 Thus, it appears that CPM
(either inhibition or facilitation) is dependent on the type of conditioning stimuli used as
well as the potential contribution of expectation of pain.
In the present study, we did not evaluate the role of expectation prior to exposure to the
VR-based MVC, however each participant was informed prior to the exposure that a
virtual collision would take place. A MVC is a traumatic stressor as evidenced by its own
nomenclature reflecting the idea that these incidents are not merely accidents,38,39 and as
such subjects could have anticipated that some degree of pain was expected. Therefore,
expectation of pain and/or injury following exposure could at the very least partially
explain the facilitated PPDT findings, though we are unable to fully account for them due
to the sample size of the study. However, this line of thinking is in agreement with the
findings of Bostick and colleagues (2009) who reported that even among healthy
Canadians without previous injury, there was widespread pessimism regarding recovery
after a potential MVC.40 As a MVC is a unique combination of physical and
psychological stressors 3,41 it may very well be that the psychological exposure of being
involved in a MVC (even a virtual one) can lead to an increase in pain sensitivity to the
point that pain is perceived from relatively low biomechanical forces.42 If such findings
are valid, both patients suffering from WAD and the clinicians treating them may have a
better understanding of why some patients acquire WAD and some do not. However,
further research is required to properly explore these theories.
Limitations
This study is not without limitations. Most noticeably, the sample size for the study was a
small convenience sample of participants. As such, we were unable to explore the
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relationships between the various measures of HRV (as well vagal rebound) and
meaningful CPM within subgroup analyses with sufficient statistical power. That being
said, this initial study was conceived as the beginning of a larger body of work exploring
the range of physiological reactions to VR-based MVC’s without potential for tissue
damage. We were also unable to capture HRV indices acutely during the virtual collision
due to the physical constraints of our data capturing system and the physical space of the
simulator. As such, we could not measure the effects of a virtual collision on HRV
indices at the time of the collision and is an area for further improvement. While we did
ask participants to refrain from any strenuous exercise or consuming any food or drink
prior to study, we did not control for time of day which may have impacted the stress
response of each participant. That said, most of the re-test data was conducted at a similar
time of day to that of each participant’s initial data collection. Salivary cortisol data was
also only available on 17 participants due to study interruptions because of the COVID19 pandemic.
Due to the shorter time frames used for analysis, we were unable to capture other HRV
indices. However, we are confident that the periods of analysis that we used were
sufficient in order to explore HRV in the time and frequency domains selected. We also
did not control for the breathing rate of each participant during HRV measurement.
However, during these periods of time participants were instructed to breathe normally,
and as such we do not believe that this would have influenced our results greatly. Also, as
participants had their HRV measured in a seated position, there may have been increased
contribution to the absolute LF values from the parasympathetic nervous system and the
baroreflex.19 Thus, we may not have been able to accurately estimate sympathetic
nervous system activity. Lastly, as this work was conducted on healthy participants, we
were unable to make direct comparisons to patients with WAD, which is an important
area for future investigation.

4.5 Conclusion
In conclusion, exposure to a VR-based MVC appears to have elicited an increase in pain
sensitivity of the trapezius muscle in up to 44% of participants. In 16% of participants
these effects persisted even up to three to seven days later upon re-test. It also appears
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that a majority of participants experienced an increase in parasympathetic nervous system
activity as measured by HRV after exposure reflecting vagal rebound which was
associated with a decrease in pain thresholds. This line of work is envisioned as the first
in exploring the range of physiological reactions to an otherwise safe and controllable
MVC with little risk of actual tissue damage. Future work should examine the effects of
exploring various simulator settings upon other physiological metrics as well as
expanding the psychological profile of the participants exposed.
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Table 10. Participant demographics. Data are presented as mean + standard
deviation with range in brackets.
Total
Sample Size (%female)

25 (36%)

Age (years)

27.3 + 4.1 (18-35)

Height (m)

1.76 + 0.09 (1.57 to 1.93)

Weight (kg)

76.23 + 19.06 (32.00 to 111.40)
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Table 11. HRV indices, PPT values, and salivary cortisol at baseline, post VR MVC,
and upon retest. Data are presented as mean + standard deviation with range in
brackets.
Baseline

Post VR MVC

Re-test (3 to 7 days)

RMSSD(ms)

39.80 + 17.08 (11.26 to 86.75)

48.63 + 19.40 (15.43 to 85.89)*

39.30 + 16.36 (13.90 to 76.66)

SDRR(ms)

57.30 + 22.53 (8.35 to 108.00)

64.47 + 22.92 (16.51 to 103.60)

57.48 + 18.36 (21.67 to 89.53)

900.96 + 766.95 (34.50 to

1262.96 + 853.38 (55.26 to

680.40 + 511.32 (76.14 to

3615.00)

3529.00)*

1834.00)

1534.42 + 1251.07 (165.20 to

2108.87 + 1332.82 (345.10 to

1557.37 + 979.01 (180.10 to

4508.00)

5350.00)*

3185.00)

HF(nu)

38.01 + 19.76 (8.99 to 74.89)

38.99 + 17.26 (5.91 to 70.41)

36.01 + 17.38 (4.89 to 69.78)

LF(nu)

59.76 + 22.79 (12.30 to 90.84)

57.20 + 20.46 (23.41 to 95.19)

62.33 + 20.49 (21.71 to 95.52)

LF/HF

2.35 + 2.12 (0.16 to 9.30)

1.79 + 1.30 (0.33 to 4.67)

2.53 + 2.37 (0.31 to 9.82)

PPT(kgf)

3.36 + 1.14 (1.31 to 5.80)

3.12 + 1.43 (0.84 to 6.56)

3.12 + 1.29 (1.28 to 5.55)

31.57 + 13.95 (15.30 to 65.81)

31.16 + 14.85 (12.13 to 65.06)

N/A

HF(ms2)

LF(ms2)

Salivary cortisol
(ng/ml)

* Significance at p<0.05 compared to baseline
Note: A logarithmic transformation was applied to HF(ms2) and LF (ms2) for statistical comparisons. RMSSD: root mean square of
successive NN interval differences; SDRR: standard deviation of the RR intervals; HF(ms2):absolute high frequency; LF(ms2):
absolute low frequency; HF(nu): normalized high frequency; LF(nu): normalized low frequency, LF/HF: frequency between low and
high frequency power; PPT(kgf): Pain pressure threshold; VR: virtual reality; MVC: motor vehicle crash.
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Table 12. CPM expressed in absolute and percent change terms for all participant,
inhibitors, facilitators, and non-responders. Data are presented as mean + standard
deviation with range in brackets.

All Participants (n =25)
PPT Inhibited (n=4)
PPT Facilitated (n= 11)
PPT Non-Response (n=10)

∆CPMABSOLUTE (kgf)

∆CPMPERCENT(%)

-0.24 + 0.68 (-1.30 to 1.15)

-8.57 + 22.40 (-52.30 to 36.64)

0.76 + 0.30 (0.48 to1.15)

24.21 + 9.16 (15.76 to 36.64)

-0.86 + 0.26 (-1.30 to -0.50)

-28.30 + 12.53 (-52.30 to -15.45)

0.04 + 0.38 (-0.39 to 0.76)

0.02 + 10.04 (-13.78 to 13. 10)

Note: PPT: Pain pressure threshold; CPM: conditioned pain modulation; kgf: kilograms of force.
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Table 13. Correlational matrix between CPM and change in HRV indices and change in salivary cortisol
CPMABS

CPMPERCENT

∆RMSSD

∆SDRR

∆HF(ms2)

∆LF(ms2)

∆HF(nu)

∆LF(nu)

∆LF/HF

∆cortisol (ng/ml)

-

0.92**

-0.34

-0.32

-0.46*

-0.38

-0.11

0.11

0.08

-0.51*

-

-0.41*

-0.41*

-0.64**

-0.48*

-0.17

0.17

0.12

-0.59*

-

0.77*

0.43*

0.00

0.34

-0.30

-0.28

0.10

∆SDRR

-

0.29

0.05

-0.01

0.03

-0.06

0.34

∆HF(ms2)

-

-

0.48*

0.48*

-0.56**

-0.66**

0.24

∆LF(ms2)

-

-

-

0.44*

0.44*

0.42

-0.09

∆HF(nu)

-

-

-

-

0.89**

-0.88**

0.06

-

0.92**

-0.25

-

0.02

CPMABS
CPMPERCENT
∆RMSSD

∆LF(nu)
∆LF/HF
∆cortisol(ng/ml)

-

Note: CPMABS: absolute change in PPT values, CPMPERCENT: percent change in PPT values, ∆RMSSD: change in root mean square of successive NN interval differences; ∆SDRR: change in standard deviation of the RR intervals;

∆HF(ms2): change in absolute high frequency; ∆ LF(ms2): change in absolute low frequency; ∆HF(nu): change in normalized high frequency; ∆LF(nu):change in normalized low frequency, ∆LF/HF: change in frequency between
low and high frequency power.

* Significance at p<0.05; **Significance at p<0.01
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Figure 4. Relationship between Percent Change CPM and Change in RMSSD values
before and after VR-based MVC. * Denotes significance at p<0.05.
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Figure 5. Relationship between Percent Change CPM and Change in Absolute High
Frequency Power before and after VR-based MVC. * Denotes significance at
p<0.01.
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Figure 6. Relationship between Absolute Change CPM and Change in Salivary
Cortisol before and after VR-based MVC. * Denotes significance at p<0.05.
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Figure 7. Relationship between Percent Change CPM and Change in Salivary
Cortisol before and after VR-based MVC. * Denotes significance at p<0.05.
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Chapter 5

5

Summary

While it appears that acute pain may confer survival value in reaction to trauma, chronic
pain may be best thought of as a disease where its effects are multidimensional, with
interactions between biology, psychology, and social factors.1 This interplay between
biological, psychological, and social factors in the context of Whiplash-Associated
Disorders (WAD) may help to explain some of the heterogeneity in presentation.2 In
development of this thesis, we approached WAD using the Integrated Model as proposed
by Walton and Elliot (2017), whereby the motor vehicle crash (MVC) acts as a
stressor/catalyst towards the development of WAD based upon the pre-existing
vulnerabilities or protections (biological, psychological, social) of the individual.3 While
we did not examine for pre-existing protections and vulnerabilities, we still performed
this research under the idea that a MVC is a unique and complex stressor that interacts
with each person uniquely. Thus, the purpose of this thesis was to explore the complex
relationship between pain and stress using a novel virtual reality (VR)-based road
collision simulator which has been designed to explore the experience of being involved
in a car crash, with comparisons to a known stressor (i.e., the cold pressor task). We
viewed this work as exploratory and likely the beginning of a new research directive
aiming to provide new avenues for exploring live, simulated traumas and to aid in
developing the types of measurements that can be used with them. This project was also
conceived as a means by which to begin to question why and how different stress
responses occur, and we hope that this knowledge will begin to shed light on competing
theories to explain such responses in the context of WAD.
In Chapter 2, we sought to explore if meaningful CPM had relationships with both the
sympathetic nervous system (SNS) and hypothalamus-pituitary-adrenal (HPA) axis
reactivity in healthy adults following exposure to the cold pressor task. Healthy
participants underwent evaluation of their pressure pain detection threshold (PPDT),
conditioned pain modulation (CPM), galvanic skin response (GSR) and salivary cortisol
both before and after a cold pressor test as a stressor (CPT). Meaningful CPM was
evaluated based on change greater than or less than 2 Standard Error of Measurement
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(SEM) of baseline PPDT to classify participants experiencing inhibition of pain,
facilitation or non-response. When meaningful CPM was assessed, only 30% of
participants experienced inhibitory CPM. Within this inhibitory CPM group, there was a
moderate positive association between CPM and the absolute change in GSR as an index
of SNS activity. In agreement with the literature, this work suggests that inhibitory CPM
is not a universally experienced phenomenon and may be related to SNS activity. Future
work may want to explore for various other individual factors that have been implicated
in CPM using this meaningful CPM framework such as sex and age.
In Chapter 3, we sought to evaluate initial tolerability to a recently developed novel VRbased road collision simulator. This was done to gather user feedback for optimization,
and to explore the development of any adverse events (i.e., reports of neck pain longer
than 48 hours, nausea, inability to tolerate VR, and disorientation). Healthy participants
had their state anxiety measured before exposure to a novel virtual reality-based rear-end
collision simulator with a small perturbation (0.2 g) at the time of simulated impact. We
also evaluated Simulator Sickness and Presence Questionnaires post-exposure. We
observed that the VR-based MVC was well tolerated by a majority of participants while
one participant (4%) reported neck pain the following day that did not last longer than 48
hours. There were no other adverse events found. There appeared to be an inverse
relationship between items on the Presence Questionnaire and Simulator Sickness
Questionnaire (greater sense of presence, less experience of sickness or nausea). It
appeared that a VR-based MVC could be safely used with healthy participants to model
MVCs, but future work is required to optimize the VR environment and to investigate the
effects of various crash parameters (e.g., direction of impact).
In Chapter 4, we began quantification of the range of physiological responses to the novel
VR-based road collision simulator. Healthy participants had their PPDT, heart rate
variability (HRV), and salivary cortisol measured before and after exposure to a novel
Virtual Reality (VR)-based rear end collision. Meaningful CPM was again determined
based on baseline PPDT to classify participants as having experienced inhibition,
facilitation, or non-response. There was an increase in HRV indices (root mean square of
the successive differences (RMSSD) between normal heartbeats, absolute high
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frequency), suggestive of an increase in parasympathetic nervous system activity after the
virtual exposure, while PPDT values remained statistically unchanged based upon group
means. When meaningful CPM was assessed, 44% of participants experienced
facilitation of their pain threshold in following the VR-based MVC. There was a low to
moderate negative association between the percent change in CPM and change in HRV
(RMSSD, absolute high frequency) indicating decreased pain thresholds were associated
with increased parasympathetic nervous system activity. There was also a negative
moderate association between percent change CPM and change in salivary cortisol. It
appeared that exposure to a VR-based MVC may increase pain sensitivity in some
participants who are exposed, which may be related to increased cortisol reactivity or
parasympathetic nervous system activity. Future work is recommended with larger
samples for confirmation of these findings.
While exposure to a cold pressor task appeared to induce decreased pain sensitivity in
some participants with an associated increase in sympathetic nervous system activity,
these findings were not replicated in a VR-based MVC. Instead, it appeared that there
was an increase in pain sensitivity associated with increased parasympathetic nervous
system activity and cortisol reactivity in the absence of injury-inducing biomechanical
forces. In reaction to a stressor, post-traumatic stress research has described that there can
be up to six different fear responses (which mainly present as sympathetic uproar and
parasympathetic shutdown), though the time spent in each is dependent on the cognitive
appraisal of the situation at hand.4 With the CPT, while participants are aware that the
stressor will be painful, their perception of it its risks may be mitigated as they remain in
control at all times during the immersion of their hand. In contrast, it could be that
participants in our VR-based MVC experienced less locus of control, which in turn elicits
a different stress response. Bolini and colleagues (2004) highlighted that in participants
who had increased locus of control over a noise-cognitive paradigm, had a decreased
cortisol response.5 Thus, we speculate that one of the major differences in these stressors
and their associated stress/pain responses is the role of expectation of injury, despite not
having measured it in this thesis.
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It is our hope that by continuing to identify the myriad of stress and startle responses to
simulated trauma, we may be better able to help identify the characteristics of individuals
who are more likely to develop WAD such that treatment options can be better tailored to
their care. While nervous system activity was measured differently across the two
stressor studies, it is possible that the results of both studies are communicating similar
findings. In reaction to the cold pressor task, participants who became less sensitive to
pain experienced an associated increase in sympathetic nervous system. Comparatively,
in reaction to a VR-based MVC, participants who became more sensitive to pain had an
association with increased parasympathetic nervous system activity. Although not
definitive, it appears that activation of the sympathetic nervous system after a trauma
(simulated or otherwise), may lead to inhibitory pain modulation while activation of the
parasympathetic nervous system, (or the absence of sympathetic tone) can lead to
facilitatory pain modulation or heightened pain sensitivity. While it remains unclear if
these nervous system activity patterns remain heightened for days after exposure, our
results suggest that different physiological responses to trauma may be helpful in
explaining the presence of alteration in pain sensitivity immediately following a stressor
(both noxious or non-noxious).
Taken together, our work suggests that the both the stress response and pain response to a
given stressor is variable and appears to be based both on the individual’s appraisal of the
stressor as well as the stressor selected. By removing participants from the VR-based
MVC, it is possible that we provided a conditioned safety stimulus, which has been
known to inhibit conditioned analgesia.4 In other words, the participant could have felt
that they were immediately placed into a safe environment, thus leading to a recovery
period of parasympathetic nervous system activity. Additionally, increases in SNS
activity following the CPT could be explained by the presence of ongoing pain and or
discomfort (even after its termination) signaling that ‘danger’ was still present. This
thesis also suggests the possibility that some individuals who are exposed to a car crash
may be at higher risk of pain and/or injury due to increased pain sensitivity resulting from
the psychological experience of involvement in a MVC. In our society, a MVC may be
considered a unique stressor due to its ability to create a fear of safety that is compounded
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by the psychosocial impacts that present following the crash (i.e., litigation, ability to pay
for services).3,6

5.1 Future Directions and Questions
As predicted, this thesis raises more questions regarding the relationship between pain
and stress than it answers. These results have opened up discussion for identifying why
some people develop WAD and others may not, but we recognize that future work is
needed to continue to identify appropriate stress/pain responses to simulated trauma. This
thesis presents the initial results and implications of the VISION project, and given the
novelty of the VISION platform, we anticipate that there will be other future
investigations into understanding WAD using controllable laboratory VR collisions.
In the context of exploring the relationship between stress system reactivity and pain, we
decided to explore these associations using simple bivariate correlations. However, after
having performed this work we acknowledge that the relationship between stress and pain
is likely a curvilinear relationship, and as such, future work will want to examine stress
and pain from this perspective. Recently, Lee and colleagues (2021) investigated the role
of blood-based protein/hormone biomarkers in the prediction of recovery following acute
musculoskeletal trauma using a cluster analysis, as opposed to simple bivariate
relationships.7 They found that in people with persistent disability there were also
moderate to high levels of serum brain derived neurotrophic factor and transforming
growth factor-beta 1. As such, the relationships between measurements of stress system
reactivity (heart rate variability, salivary cortisol, galvanic skin response) and pain could
be explored using such cluster analysis in future research to help predict recovery from
trauma.
While we chose to examine the immediate pain and stress response to controlled
stressors, other research teams have spent great time trying to predict recovery from
trauma. These investigations have appeared to consistently highlight three unique
trajectory pathways: those very likely to recover, likely to recovery, and not likely to
recover.8,9 At the same time, our work adds to the growing body of literature suggesting
that Conditioned Pain Modulation (CPM) also consists of three unique responses, namely
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inhibition, facilitation, and non-response.10,11 At this point, it is unclear if these three
CPM responses align with trajectories predicting recovery. As interest in CPM as a
biomarker for chronic pain continues to increase,12 future work may want to identify if
these CPM responses can aid in identification of those likely to recover from trauma or
not. Additionally, those investigating exercise-induced analgesia may want to evaluate
meaningful CPM, as inefficient CPM and impaired exercise-induced analgesia have been
linked in patients with other chronic conditions such as knee osteoarthritis.13
One of the most surprising findings of this thesis was that that over 40% of healthy
participants who were exposed to a virtual rear-end MVC exhibited increased mechanical
pain sensitivity of their upper fibers of trapezius immediately post-collision. This finding
is of particular interest as it may help to shed light on those participants who present with
neck pain from low-speed collisions. It may be that the acquisition of neck pain following
a MVC is due to a combination of the psychological exposure of the experience as well
as any biomechanical forces imparted during said collision. As this finding was not
replicated in all subjects, it is suggestive that there are different responses to being
involved in a MVC which may help to explain the heterogeneity of WAD.3 Increased
pain sensitivity may also have implications in the areas of recent imaging studies which
have found fatty muscle infiltrate of the cervical musculature in chronic WAD
patients.14,15 It may very well be that an immediate increase in pain sensitivity,
compounded by the presence of biomechanical forces and/or other psychological
stressors leads to a learned disuse of the neck musculature causing fatty muscle
infiltration.15 Future work will want to examine increased pain sensitivity shortly after the
time of injury to prevent these secondary sequelae from occurring.
Lastly, this thesis only examined the effects of a rear-end VR-based MVC upon healthy
participants. The VISION platform is capable of manipulation of collision type (e.g.,
rear-end vs front end) as well as other variables such as audiovisual knowledge of an
impending collision. Future studies may want to manipulate these variables to gain
further insight into the various pain and stress responses that may present in addition to
examining how WAD patients may react to these stimuli. In the current study, we
informed participants that a rear-end collision would occur, but did not say exactly when
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it would happen. Future studies could attempt to manipulate the participants knowledge
of the impending MVC to evaluate differential responses. For example, informing
participants that a car crash would occur but not saying which type versus telling them
exactly when the collision may take place would be of particular interest with respect to
locus of control. Finally, to ensure that the simulator is adequately representing a MVC,
qualitative inquiry with MVC survivors would be helpful to understand the experience of
being involved in a MVC. Methodological approaches such as Qualitative Description,
have been reported appropriate when specific descriptions of a phenomenon are desired
and allow for a flexible yet simplistic approach to understanding such experiences,
especially when there is a lack of information on a given topic.16,17 Qualitative inquiries
would be helpful in continuing to understand why MVC’s and WAD affect different
people differently and continue to shed light on this condition that continues to plague its
sufferers.
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Appendix C: VISION Pt. I Letter of Information and Consent
Quantification of the stress response(s) and changes in conditioned pain
modulation in reaction to the cold pressor task
LETTER OF INFORMATION AND CONSENT
Principal Investigator
Dr. David Walton PT PhD
Western University
Elborn College
London, ON

Funding: Faculty Scholar Award & Chronic Pain Network Grant
Dear Sir/Madam,
Thank you for your time in reviewing this letter of information and for considering
participation in our study. Please be sure you’ve read this letter in its entirety and have
had any questions answered to your satisfaction before consenting to participate.
Invitation to Participate
You are being invited to participate in a study examining how pain can change following
an acute stressful event. You are being invited because you have indicated that you are
otherwise healthy and have had no recent trauma or injury affecting your muscles, joints,
bones or ligaments in the previous 2 weeks. Furthermore, you are at least 18 years of age
and are able to read and understand conversational English.
In order to be eligible to participate, you must not have any of the following conditions.
Please tell the research coordinator if any of these apply to you.
1. Significant health conditions including infection or a history of cardiovascular
instability (e.g., heart disease, high or low blood pressure)
2. Actively undergoing cancer treatment
3. Any health condition that affects your reaction to cold, including conditions such
as Raynaud’s phenomenon or cryoglobulinemia
4. Any health condition that impairs your ability to feel touch or temperature,
including stroke, multiple sclerosis, amyotrophic lateral sclerosis, or nerve pinch
in your neck.
What the purpose of this study?
We are evaluating how your sensitivity to pressure can be altered by a stressful event, and
why that might occur. We will ask you to dip your hand into cold water (a task known as
the Cold Pressor Task), which considerable prior research has used as a low risk and
reliable way to create stress. We will also be examining the effects of some of your
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personal attributes like your biological sex or gender orientation on your pain sensitivity.
The results of this study will help us better understand the connections between pain and
stress.
How long will you be in the study?
This study will occur over two 1-hour sessions separated by about one week (2 hours
total commitment).
What are the study procedures?
If you agree to participate, the study will be conducted in the Pain and Quality of Life
Integrative Research Lab (P.I.R.L.) located in Elborn College, Western University in
London, ON. Prior to your visit you are asked to avoid eating, drinking sugary or
caffeinated drinks or participating in vigorous activity for the hour prior. On each visit,
the following procedures will occur:
1. You will be asked to complete a few questionnaires. These will start by asking
things about you: your age, height, weight, sex at birth, time you awoke that day,
and the quality of sleep you had the previous night. You will also be asked to
complete the Gender and Pain Expectation Scale that will ask you questions about
how well different traits describe you and your beliefs about your sensitivity to
pain compared to other people like you. Finally, you will be asked 6 short
questions about your current level of anxiety.
2. Next, the researchers will place recording electrodes on your chest to measure
your heart rate, and on two finger tips of your non-dominant hand to measure
your skin’s reaction to stress. You will have the option of placing the electrodes
yourself according to a diagram or having the researchers do it for you. A
standard inflatable blood pressure cuff will be wrapped around your upper arm.
Then you will be invited to sit comfortably for 5 minutes while the researchers
record data coming from the different sensors. At the end of the 5 minutes you
will be asked to provide a small sample of saliva by placing a sterile cotton swab
under your tongue for about 10 seconds before sealing it in a tube. It is important
to note that none of the data we are collecting can be used for diagnostic purposes,
however if your blood pressure should be very high, we will let you know and
suggest some options you may wish to explore. Finally, your sensitivity to
pressure will be tested by one of the researchers who will apply pressure using a
battery-powered device with a small rubber tip with slowly increasing force until
you indicate the sensation is painful.
3. Next, you will be asked to submerge your dominant hand into a container of cold
water (approximately 3-4 degrees Celsius) up to the wrist. During this time the
researchers will continue to collect the information from the sensors connected to
you. You will also be asked to rate your current pain on a scale of 0 (no pain) to
10 (extreme pain) every 10 seconds. You are encouraged to keep your hand in the
water for up to 90 seconds but may remove your hand at any point if you should
choose to do so.
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4. After your hand has been removed from the water and dried, the researchers will
retest your pain sensitivity with the same rubber-tipped device. You will also be
asked to provide one more saliva sample. You will then be asked to sit
comfortably for another 5-minute period while heart rate, skin reactivity, and
blood pressure are collected. During this time you will be asked to complete the 6
anxiety questions one more time.
You will be asked to come back to the PIRL for the exact same testing protocol
approximately 1 week later.
What are the risks and benefits of participating?
There are no immediate direct benefits for participation in this study. However, we
believe the information obtained will help us and others studying pain to better
understand the various influences on the experience.
The perceived risks of participation are minimal. The most evident risk is a momentary
increase in pain and/or stiffness as a result of keeping your hand in the cold water for 1
minute, but this should resolve after you start moving it once more. Additionally, as this
is a pain provocation test, you will experience cold pain while your hand is submerged.
The cold-water, while uncomfortable, is non-damaging in nature. There is little to
minimal risk of frostbite and you are in complete control of all aspects of this test. You
may remove your hand at any point if you choose. However, in the event that frostbite
occurs, your hand will be immediately removed from the cold water, dried, and you will
be taken to the closest Emergency Department (University Hospital) for medical
management. Again, the risk of this is extremely minimal. Finally, you are likely to
experience some increased heart rate, blood pressure, or sweating due to the cold-water
immersion of your hand. Again, you are in complete control of the study and may remove
your hand from the cold water at any point. Also, the researchers will be monitoring your
heart rate during the study and if it should get too high (above 80% of your age-adjusted
maximum) they will stop the study. It is possible that you will see a bit of bruising around
the area of the pressure pain test.
All data will be secured, but there is a chance of a privacy breach, in which case you will
be immediately informed.
In addition, there is a small chance that you may experience some irritation or a potential
allergy to the gel used for the heart rate monitoring. If you are aware of any skin
sensitivities to gel or adhesives, please let the researchers know ahead of time. If you do
begin to experience itch or redness under any of the recording electrodes, the study will
be stopped and medical management, if needed, will be offered.
Finally, you will be asked to rate your own stress, anxiety and fear as part of this study.
For some, providing personal information regarding your own anxieties and fears can be
a difficult experience. Once again, you are in complete control and may choose to not
provide this information.
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Please note that medical treatment in the event of study related injury would be provided
at no additional cost.
Reminders and Responsibilities
Participants will be required to refrain from eating, drinking sugary or caffeinated drinks,
or engaging in vigorous physical activity (e.g., going to the gym) for the hour prior to
each data collection period described above. In addition, please do not smoke or chew
gum prior to your lab visit.
How will participants’ information be kept confidential?
All information will be kept confidential to the best of our ability. Your data will be
stored separately from any information that could connect you to it. A unique 4-digit ID
number will be generated for you and will be attached to your results in the study. The
primary investigator at Western University, Dr. David Walton and PhD Student Michael
Lukacs, will collect all of the data provided and analyze it as a de-identified group. All
data will be stored on the secure, password protected and firewalled server of Western
University. Identifying information will be retained for 7 years after study completion as
per institutional policy. Western University’s REB will have access to participant’s data
to ensure that it is following the proper laws and regulations. Outside of these
acknowledged groups, your specific information (i.e., name) will not be shared with
anyone without your express written consent to do so. Note: Only group averages will
ever be published and you will not be identified. Data will be retained for a period of 7
years before they are destroyed. You are free to request the removal of your data from the
study up until this point.
Will I be compensated for my participation?
There is no direct financial compensation for participation in this study. However, those
who incur costs beyond their usual daily routines (e.g., having to drive and park at Elborn
College for this study) will have those costs reimbursed.
What are the Rights of Participants?
Participation in this study is completely voluntary. You may choose to not participate,
withdraw from the study at any point in time without penalty and without any explanation
required. If you choose not to participate or to leave the study at any time it will have no
effect on your academic standing or your relationship with Western University or the
researchers. Additionally, if you withdraw, you may request to have your data withdrawn
from the study. Participation in this study does not prevent you from participating in any
other research studies at the present time or future. If you are participating in another
research study, we ask that you please inform of us of your participation. You do not
waive any legal rights by signing the consent form.
What if I want more information?
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You may contact the lead researcher, Dr. David Walton at Western University (London,
Canada) if you require any further clarification. His contact information can be found on
the first page of this document. If you have any questions regarding your rights as a
participant in this research study or the conduct of the study, you may contact the Office
of the Research Ethics at (519) 661-3036 or by e-mail at ethics@uwo.ca.
In addition, if you wish to receive a summarized copy of the results of this study, you
may leave your email address on a separate sheet. This sheet will be held by the lead
researcher, and the email address will only be used to provide the summarized results,
after which the list will be destroyed.
We thank you in advance for considering participation in this study.
This letter is yours to keep for future reference.
Sincerely,
Dr. David Walton PT PhD
Michael Lukacs PT, PhD Student
Mohamad Fakhereddin, PhD Student
Maryam Ghodrati, PhD Student
Walter Siqueira, DDS, PhD
Sandro Cestra, MPT Student
Henry Tan, MPT Student
Carmen Fung, MPT Student
Harleen Nijjar, MPT Student
Julian Quaglia, MPT Student
Jaipaul Dhaliwal, MPT Student

106

If any part of this study causes you stress or anxiety that you find difficult to deal with,
please feel free to contact us directly. The lead researcher is Dr. David Walton.

You may also find the following resources helpful for dealing with stress:
1. Supportive Family Member or Friend
2. Your Family Doctor or Other Healthcare Provider
3. Psychological Services (in your neighborhood hospital, university, or clinic)
4. Telephone Support Lines (London and District Distress Centre; available 24
hours/day)
Distress Line
519-667-6711
Crisis Response Line
519-433-2023
5. Telehealth Ontario (available 24 hours/day)

1-866-797-0000
If your blood pressure should be abnormally high, or outside of normal range, you will
receive a written note on the day of testing, and it will be suggested that you should
consult your family doctor.
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Consent Form
Quantification of the stress response(s) and changes in conditioned pain modulation
in reaction to the cold pressor task

I have read the letter of information, have had the nature of the study explained to me and
I agree to participate. All questions have been answered to my satisfaction.

Participant name (print)

Participant signature

Date

Person obtaining consent (print)

Date

Signature of person obtaining consent
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Appendix D: VISION Pt. II Letter of Information and Consent
Quantifying the normal stress response(s) and change in conditioned pain
modulation following a novel virtual road collision simulation
LETTER OF INFORMATION AND CONSENT
Principal Investigator
Dr. David Walton PT PhD
Western University
Elborn College
London, ON
Funding: Bone and Joint Institute Transdisciplinary Award
Dear Sir/Madam,
Thank you for your time in reviewing this letter of information and for considering
participation in our study. Please be sure you’ve read this letter in its entirety and have
had any questions answered to your satisfaction before consenting to participate.
Invitation to Participate
You are being invited to participate in a study examining how healthy people react to
being exposed to a virtual reality car crash. You are being invited because you have
indicated that you are otherwise healthy and have had no recent trauma or injury affecting
your muscles, joints, bones or ligaments in the previous 3 months . Furthermore, you are
at least 18 years of age and are able to read and understand conversational English.
In order to be eligible to participate, you must not have any of the following conditions.
Please tell the research coordinator if any of these apply to you.
1. Significant health conditions including infection or a history of cardiovascular
instability (e.g., heart disease, high or low blood pressure)
2. Actively undergoing cancer treatment
3. Any health condition that impairs your ability to feel touch, including stroke,
multiple sclerosis, amyotrophic lateral sclerosis, or nerve pinch in your neck.
4. An inability to have your cervical neck tested for dysfunction
5. Neurological or systemic conditions that affect balance or postural control, and
vestibular conditions that would affect ability to use virtual reality such as Vertigo
or Benign paroxysmal positional vertigo (BPPV) (i.e. a disorder of the inner ear
affecting balance)
6. Have a history of migraines
7. Visual pathology such as eye saccades (i.e. rapid eye movements) or other visual
or movement-related disturbances
8. Technophobia or fear of technology
9. Claustrophobia or any fear of enclosed spaces
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What the purpose of this study?
Until now, it has been impossible to examine the range of stress responses for those
involved in a car crash, especially at the time of the crash. We have successfully
developed a new virtual reality-based road collision simulator that is designed to simulate
the experience of being in a car crash without any of the biomechanical trauma. Thus, the
purpose of this study is to examine how healthy people react to being part of a virtual car
crash. We hope that the results of this study will help us better understand the
connections between pain and stress. This study is conducted as part of the PhD work for
PhD candidate Michael Lukacs.
How long will you be in the study?
This study will occur over two sessions separated by about one week, with the first one
lasting just over an hour, and the second lasting only 20 minutes (roughly 2 hours total
commitment).
What are the study procedures?
If you agree to participate, the study will be conducted in the Robot Biomechanics lab
located in 030 1R16 in the Arts and Humanities Building, Western University in London,
ON. Prior to your visit you are asked to avoid eating, drinking sugary or caffeinated
drinks or participating in vigorous activity for the hour prior. As part of the screening
process, your neck will be screened for dysfunction. You will be asked to rotate your
head from side to side to ensure that you have full, pain-free range of motion of your
cervical spine. You will then be asked to side-bend and rotate your head while a small
amount of pressure is applied to the top of the head. Any production of symptoms would
warrant exclusion from the study. On your visit, the following procedures will occur:
5. You will be asked to complete a few questionnaires. These will start by asking
things about you: your age, height, weight, sex at birth, time you awoke that day,
and the quality of sleep you had the previous night. You will also be asked 6 short
questions about your current level of anxiety. Finally, you will be asked a series
of 9 questions regarding your fear of pain.
6. Next, the researchers will place recording electrodes on your chest to measure
your heart rate, and on two fingertips of your non-dominant hand to measure your
skin’s reaction to stress. You will have the option of placing the electrodes
yourself according to a diagram or having the researchers do it for you. Then you
will be invited to sit comfortably for 5 minutes while the researchers record data
coming from the different sensors. During these 5 minutes, you will be asked to
refrain from using any electronic devices. At the end of the 5 minutes you will be
asked to provide a small sample of saliva by placing a sterile cotton swab under
your tongue for about 10 seconds before sealing it in a tube. It is important to note
that none of the data we are collecting can be used for diagnostic purposes.
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Finally, your sensitivity to pressure will be tested by one of the researchers who
will apply pressure using a battery-powered device with a small rubber tip into
your trapezius muscle with slowly increasing force until you indicate the
sensation is painful.
7. Next, you will be asked to sit in a car seat attached to a robot that is designed to
mimic the movements of a car during driving. You will also be asked to wear a
virtual reality helmet which will display the visuals of the simulation. In this
simulation you will experience the role of being a passenger in a car. In addition,
we will ask you to wear noise-cancelling headphones such that you are further
immersed in the simulation. The movements of the robotic platform are
synchronized with the visuals of the VR helmet in order to increase the
immersiveness of the simulation. For example, as you view the car turning a
corner, the robot will also turn accordingly. In order to see how you tolerate being
exposed to virtual reality, you will be exposed to a driving route with no crash for
5 minutes in duration. You will be given 1 minute of rest. During this rest period,
you will be asked to refrain from using electronic devices.
8. You will again be asked to be exposed to a virtual driving route, but this time
there will be a virtual car crash. During this crash, the platform you are sitting on
will exert a small force against you to increase your immersion of feeling like you
are in a car crash. The platform you are sitting on cannot accelerate beyond 1g,
which is the equivalent of you sneezing. At any point you are free to quit the
simulation should you choose. This route is only expected to take 1 minute in
length.
9. Immediately after the virtual car crash, the researchers will retest your pain
sensitivity with the same rubber-tipped device. You will then be asked to sit
comfortably for another 10-minute period while heart rate, and skin reactivity are
continuously measured. At 5 minutes post, one more saliva sample will be
collected using the same poly-cotton swabs. The researchers will re-evaluate your
pain sensitivity every 3 minutes following. At the end of the 10 minutes, the
researchers will ask you 6 questions to evaluate your anxiety, and 2
questionnaires regarding both the immersiveness of the virtual simulation and the
extent to which you experienced nausea or not.
You are invited to come back for a second visit 3 to 7 days later to have your pain
sensitivity, heart rate, and skin sensitivity re-evaluated under the same environmental
conditions for evaluation of their test-retest reliability following the virtual car crash
exposure. This is an optional study visit and your initial data will still be used even if you
do not return. This second testing session does not include a virtual car crash and is
expected to take 10-15 minutes.
What are the risks and benefits of participating?
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There are no immediate direct benefits for participation in this study. However, we
believe the information obtained will help us and others studying pain to better
understand the various influences of stress on the development of pain following
injury/trauma.
The perceived risks of participation are minimal. The most evident risk is a momentary
increase the stiffness of the muscles of your neck, but this should resolve after you start
moving it once more. You are also likely to experience some increased heart rate, blood
pressure, or sweating due to stressful nature of the car crash simulation. Again, you are in
complete control of the study and may quit the study at any time, should you choose to do
so. Also, the researchers will be monitoring your heart rate during the study and if it
should get too high (above 80% of your age-adjusted maximum) they will stop the study.
It is also possible that you will see a bit of bruising around the area of the pressure pain
test. Due to the nature of virtual reality, there is a very small risk that you may experience
some nausea after experiencing the simulation. From previous work in our lab examining
virtual reality and neck movement, nausea following exposure to virtual reality did not
last longer than 24 hours.
As we are examining the hypothesis that neck pain may be due to stress, it is possible that
some people may experience pain and/or stiffness of the neck following exposure to the
simulation. We expect these symptoms to be short-lived (i.e., not lasting more than 1-2
days). We are confident that the magnitude of force that you will be exposed to in the
simulator is not great enough to cause damage to the tissues of the neck. However, in the
event that you should experience neck pain and/or stiffness that persist greater than 1-2
days, we would ask you to follow up with your family physician for medical
management. We will also send your family physician a letter outlining the nature of the
study and the simulation that you were exposed to.
All data will be secured, but there is a chance of a privacy breach, in which case you will
be immediately informed.
In addition, there is a small chance that you may experience some irritation or a potential
allergy to the gel used for the heart rate monitoring. If you are aware of any skin
sensitivities to gel or adhesives, please let the researchers know ahead of time. If you do
begin to experience itch or redness under any of the recording electrodes, the study will
be stopped and medical management, if needed, will be offered.
Finally, you will be asked to rate your own stress, anxiety and fear as part of this study.
For some, providing personal information regarding your own anxieties and fears can be
a difficult experience. Once again, you are in complete control and may choose to not
provide this information.
Please note that medical treatment in the event of study related injury would be provided
at no additional cost.
Reminders and Responsibilities
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Participants will be required to refrain from eating, drinking sugary or caffeinated drinks,
or engaging in vigorous physical activity (e.g., going to the gym) for the hour prior to
each data collection period described above. In addition, please do not smoke or chew
gum prior to your lab visit.
How will participants’ information be kept confidential?
All information will be kept confidential to the best of our ability. Your data will be
stored separately from any information that could connect you to it. A unique 4-digit ID
number will be generated for you and will be attached to your results in the study. The
primary investigator at Western University, Dr. David Walton and PhD Student Michael
Lukacs, will collect all of the data provided and analyze it as a de-identified group. All
data will be stored on the secure, password protected and firewalled server of Western
University. Identifying information such as your full name, age, email address, sex and
gender will be retained for 7 years after study completion as per institutional policy.
Western University’s REB will have access to participant’s data to ensure that it is
following the proper laws and regulations. Outside of these acknowledged groups, your
specific information (i.e., name) will not be shared with anyone without your express
written consent to do so. Note: Only group averages will ever be published and you will
not be identified. Data will be retained for a period of 7 years before they are destroyed.
You are free to request the removal of your data from the study up until this point.
Will I be compensated for my participation?
There is no direct financial compensation for participation in this study. However, those
who incur costs beyond their usual daily routines (e.g., having to drive and park at
Western University for this study) will have those costs reimbursed.
What are the Rights of Participants?
Participation in this study is completely voluntary. You may choose to not participate,
withdraw from the study at any point in time without penalty and without any explanation
required. If you choose not to participate or to leave the study at any time it will have no
effect on your academic standing or your relationship with Western University or the
researchers. Additionally, if you withdraw, you may request to have your data withdrawn
from the study. Participation in this study does not prevent you from participating in any
other research studies at the present time or future. If you are participating in another
research study, we ask that you please inform of us of your participation. You do not
waive any legal rights by signing the consent form.
What if I want more information?
You may contact the lead researcher, Dr. David Walton at Western University (London,
Canada) if you require any further clarification. His contact information can be found on
the first page of this document. If you have any questions regarding your rights as a
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participant in this research study or the conduct of the study, you may contact the Office
of the Research Ethics at (519) 661-3036 or by e-mail at ethics@uwo.ca.
In addition, if you wish to receive a summarized copy of the results of this study, you
may leave your email address on a separate sheet. This sheet will be held by the lead
researcher, and the email address will only be used to provide the summarized results,
after which the list will be destroyed.
We thank you in advance for considering participation in this study.
This letter is yours to keep for future reference.
Sincerely,
Dr. David Walton PT, PhD
Dr. James Dickey PhD
Michael Lukacs PT, PhD(c)

If any part of this study causes you stress or anxiety that you find difficult to deal with,
please feel free to contact us directly. The lead researcher is Dr. David Walton. In
addition, if you do have neck pain, headache, and/or nausea persisting for more than 1-2
days please do not hesitate to contact us.
You may also find the following resources helpful for dealing with stress:
10. Supportive Family Member or Friend
11. Your Family Doctor or Other Healthcare Provider
12. Psychological Services (in your neighborhood hospital, university, or clinic)
13. Telephone Support Lines (London and District Distress Centre; available 24
hours/day)
Distress Line
519-667-6711
Crisis Response Line
519-433-2023
14. Telehealth Ontario (available 24 hours/day)
1-866-797-0000
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Consent Form
Quantification of the stress response(s) and changes in conditioned pain modulation
in reaction to the cold pressor task
I have read the letter of information, have had the nature of the study explained to me and
I agree to participate. All questions have been answered to my satisfaction.

Participant name (print)

Participant signature

Date

Person obtaining consent (print)

Date

Signature of person obtaining consent
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Appendix E: State-Trait Anxiety Inventory-6 (STAI-6)

A number of statements which people have used to describe
themselves are given below. Read each statement and then circle
the most appropriate number to the right of the statement to
indicate how you feel right now, at this moment. There are no right
or wrong answers. Do not spend too much time on any one
statement but give the answer which seems to describe your
present feelings best.

Not at all Somewhat Moderately Very Much
1.
2.
3.
4.
5.
6.

I feel calm………….
I am tense………….
I feel upset…………
I am relaxed……….
I feel content……….
I am worried……….

1
1
1
1
1
1

2
2
2
2
2
2

3
3
3
3
3
3

4
4
4
4
4
4

116

Appendix F: Fear of Pain Questionnaire (FPQ-9)
The items listed below describe painful experiences. Please look at each item and think
about how FEARFUL you are of experiencing the PAIN associated with each item. If you
have never experienced the PAIN of a particular item, please answer on the basis of how
FEARFUL you expect you would be if you had such an experience. Circle one number for
each item below to rate your FEAR OF PAIN in relation to each event.
Not at
all
1

Somewhat

Moderately

Extreme

3

Very
Much
4

2

2.Having a foot
doctor remove a
wart from your
foot with a sharp
instrument

1

2

3

4

5

3.Getting a
papercut on your
finger
4.Receiving an
injection in your
mouth

1

2

3

4

5

1

2

3

4

5

5.Getting strong
soap in both your
eyes while bathing
or showering

1

2

3

4

5

6.Having someone
slam a heavy car
door on your hand

1

2

3

4

5

7.Gulping a hot
drink before it has
cooled

1

2

3

4

5

8.Receiving an
injection in your
hip/buttocks

1

2

3

4

5

9.Falling down a
flight of concrete
stairs

1

2

3

4

5

1.Breaking your
arm

5
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Appendix G:Presence Questionnaire
Characterize your experience in the environment, by marking an "X" in the appropriate
box of the 7-point scale, in accordance with the question content and descriptive labels.
Please consider the entire scale when making your responses, as the intermediate levels
may apply. Answer the questions independently in the order that they appear. Do not skip
questions or return to a previous question to change your answer.
WITH REGARD TO THE EXPERIENCED ENVIRONMENT
1. How much were you able to control events?
|________|________|________|________|________|________|________|
NOT AT ALL

SOMEWHAT

COMPLETELY

2. How responsive was the environment to actions that you initiated (or performed)?
|________|________|________|________|________|________|________|
NOT

MODERATELY

COMPLETELY

RESPONSIVE

RESPONSIVE

RESPONSIVE

3. How natural did your interactions with the environment seem?
|________|________|________|________|________|________|________|
EXTREMELY

BORDERLINE

ARTIFICAL

COMPLETELY
NATURAL

4. How much did the visual aspects of the environment involve you?
|________|________|________|________|________|________|________|
NOT AT ALL

SOMEWHAT

COMPLETELY

5. How natural was the mechanism which controlled movement through the
environment?
|________|________|________|________|________|________|________|
EXTREMELY

BORDERLINE

ARTIFICIAL

COMPLETELY
NATURAL

6. How compelling was your sense of objects moving through space?
|________|________|________|________|________|________|________|
NOT AT ALL
COMPELLING

MODERATELY

VERY
COMPELLING
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7. How much did your experiences in the virtual environment seem consistent with your
real world experiences?
|________|________|________|________|________|________|________|
NOT

MODERATELY

CONSISTENT

CONSISTENT

VERY
CONSISTENT

8. Were you able to anticipate what would happen next in response to the actions that you
performed?
|________|________|________|________|________|________|________|
NOT AT ALL

SOMEWHAT

COMPLETELY

9. How completely were you able to actively survey or search the environment using
vision? |________|________|________|________|________|________|________|
NOT AT ALL

SOMEWHAT

COMPLETELY

10. How compelling was your sense of moving around inside the virtual environment?
|________|________|________|________|________|________|________|
NOT

MODERATELY

VERY

COMPELLING

COMPELLING

COMPELLING

11. How closely were you able to examine objects?
|________|________|________|________|________|________|________|
NOT AT ALL

PRETTY
CLOSELY

VERY
CLOSELY

12. How well could you examine objects from multiple viewpoints?
|________|________|________|________|________|________|________|
NOT AT ALL

SOMEWHAT

EXTENSIVELY

13. How involved were you in the virtual environment experience?
|________|________|________|________|________|________|________|
NOT
INVOLVED

MILDLY
INVOLVED

COMPLETELY
ENGROSSED
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14. How much delay did you experience between your actions and expected outcomes?
|________|________|________|________|________|________|________|
NO DELAYS

MODERATE

LONG

DELAYS

DELAYS

15. How quickly did you adjust to the virtual environment experience?
|________|________|________|________|________|________|________|
NOT AT ALL

SLOWLY

LESS THAN
ONE MINUTE

16. How proficient in moving and interacting with the virtual environment did you feel at
the end of the experience?
|________|________|________|________|________|________|________|
NOT

REASONABLY

VERY

PROFICIENT

PROFICIENT

PROFICIENT

17. How much did the visual display quality interfere or distract you from performing
assigned tasks or required activities?
|________|________|________|________|________|________|________|
NOT AT ALL

INTERFERED

PREVENTED

SOMEWHAT

TASK PERFORMANCE

18. How much did the control devices interfere with the performance of assigned tasks or
with other activities?
|________|________|________|________|________|________|________|
NOT AT ALL

INTERFERED

INTERFERED

SOMEWHAT

GREATLY

19. How well could you concentrate on the assigned tasks or required activities rather
than on the mechanisms used to perform those tasks or activities?
|________|________|________|________|________|________|________|
NOT AT ALL

SOMEWHAT

COMPLETELY
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Appendix H: Simulator Sickness Questionnaire
Instructions: Circle how much each symptom is affecting you right now.
1. General Discomfort

None

Slight

Moderate

Severe

2. Fatigue

None

Slight

Moderate

Severe

3. Headache

None

Slight

Moderate

Severe

4. Eye Strain

None

Slight

Moderate

Severe

5. Difficulty Focusing

None

Slight

Moderate

Severe

6. Salivation Increasing

None

Slight

Moderate

Severe

7. Sweating

None

Slight

Moderate

Severe

8. Nausea

None

Slight

Moderate

Severe

9. Difficulty Concentrating

None

Slight

Moderate

Severe

10. Fullness of the Head

None

Slight

Moderate

Severe

11. Blurred Vision

None

Slight

Moderate

Severe

12. Dizziness With Eyes Open

None

Slight

Moderate

Severe

13. Dizziness With Eyes Closed

None

Slight

Moderate

Severe

14. Vertigo

None

Slight

Moderate

Severe

15. Stomach Awareness

None

Slight

Moderate

Severe

16. Burping

None

Slight

Moderate

Severe

*Vertigo is experienced as a loss of orientation with respect to vertical upright

**Stomach awareness is usually used to indicate a feeling of discomfort which is just
short of nausea
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